(ROOT
  (S
    (S
      (NP
        (NP (NNP Haploinsufficiency))
        (PP (IN for)
          (NP (NNP BRCA1))))
      (VP (VBZ is)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (JJ normal) (NNS levels))
              (PP (IN of)
                (NP
                  (NP
                    (NP (NNP DNA) (NN nucleotide) (NN excision) (NN repair))
                    (PP (IN in)
                      (NP (NN breast) (NN tissue))))
                  (CC and)
                  (NP
                    (NP (NN blood) (NNS lymphocytes))
                    (NP (NNP Abstract) (NNP Background))))))))))
    (: :)
    (S
      (NP (NNP Screening))
      (ADVP (RB mammography))
      (VP
        (VP (VBZ has)
          (VP (VBN had)
            (NP
              (NP (DT a) (JJ positive) (NN impact))
              (PP (IN on)
                (NP (NN breast) (NN cancer) (NN mortality))))))
        (CC but)
        (VP (MD can) (RB not)
          (VP (VB detect)
            (NP (DT all) (NN breast) (NNS tumors))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT a) (JJ small) (NN study)))
    (, ,)
    (NP (PRP we))
    (VP (VBD confirmed)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ low) (NN power) (JJ magnetic) (NN resonance) (NN imaging))
            (PRN (-LRB- -LRB-)
              (NP (NNP MRI))
              (-RRB- -RRB-)))
          (VP (MD could)
            (VP (VB identify)
              (NP
                (ADJP (RB mammographically) (JJ undetectable))
                (NNS tumors))
              (PP (IN by)
                (S
                  (VP (VBG applying)
                    (NP (PRP it))
                    (PP (TO to)
                      (NP (DT a) (JJ high) (NN risk) (NN population)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Tumors))
      (VP (VBN detected)
        (PP (IN by)
          (NP (DT this) (JJ new) (NN technology)))))
    (VP
      (VP (MD could)
        (VP (VB have)
          (NP (JJ unique) (JJ etiologies) (NN and/or) (NNS presentations))))
      (, ,)
      (CC and)
      (VP (MD may)
        (VP (VB represent)
          (NP
            (NP (DT an) (VBG increasing) (NN proportion))
            (PP (IN of)
              (NP (JJ clinical) (NN practice))))
          (SBAR (IN as)
            (S
              (NP (JJ new) (NN screening) (NNS methods))
              (VP (VBP are)
                (VP (VBN validated)
                  (CC and)
                  (VBN applied))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A)
        (ADJP (RB very) (JJ important))
        (NN aspect))
      (PP (IN of)
        (NP (DT this) (NN etiology))))
    (VP (VBZ is)
      (NP
        (NP (JJ genomic) (NN instability))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBZ is)
              (VP (VBN associated)
                (PP (IN with)
                  (NP
                    (NP (DT the) (NN loss))
                    (PP (IN of)
                      (NP
                        (NP (NN activity))
                        (PP (IN of)
                          (NP (DT the) (NN breast) (NN cancer-predisposing) (NNS genes) (NNP BRCA1)
                            (CC and)
                            (NNP BRCA2)))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (JJ sporadic) (NN breast) (NN cancer)))
    (, ,)
    (ADVP (RB however))
    (, ,)
    (NP (EX there))
    (VP (VBZ is)
      (NP
        (NP (NN evidence))
        (PP (IN for)
          (NP
            (NP (DT the) (NN involvement))
            (PP (IN of)
              (NP
                (NP (DT a) (JJ different) (NN pathway))
                (PP (IN of)
                  (NP
                    (NP (NN DNA) (NN repair))
                    (, ,)
                    (NP
                      (NP (JJ nucleotide) (NN excision) (NN repair))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP NER))
                        (-RRB- -RRB-))
                      (, ,)
                      (SBAR
                        (WHNP (WDT which))
                        (S
                          (VP (VBZ remediates)
                            (NP
                              (NP (NNS lesions))
                              (SBAR
                                (WHNP (WDT that))
                                (S
                                  (VP (VBP cause)
                                    (NP
                                      (NP (DT a) (NN distortion))
                                      (PP (IN of)
                                        (NP (DT the) (NNP DNA) (NN helix)))
                                      (, ,)
                                      (PP (VBG including)
                                        (NP (NN DNA) (NNS cross-links))))))))))))))))))))
    (. .)))

(ROOT
  (FRAG
    (NP (NN Case) (NN presentation))
    (: :)
    (S
      (NP (PRP We))
      (VP (VBP describe)
        (NP (DT a) (NN breast) (NN cancer) (NN patient))
        (PP (IN with)
          (NP
            (NP (DT a)
              (ADJP (RB mammographically) (JJ undetectable))
              (NN stage) (NN I) (NN tumor))
            (VP (VBN identified)
              (PP (IN in)
                (NP (PRP$ our) (NNP MRI) (NN screening) (NN study))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP She))
    (VP (VBD was)
      (ADVP (RB originally))
      (VP (VBN considered)
        (S
          (VP (TO to)
            (VP (VB be)
              (UCP
                (PP (IN at)
                  (NP
                    (NP (JJ high) (NN risk))
                    (ADJP (JJ due)
                      (PP (TO to)
                        (NP
                          (NP
                            (NP (DT the) (JJ familial) (NN occurrence))
                            (PP (IN of)
                              (NP (NN breast))))
                          (CC and)
                          (NP
                            (NP (JJ other) (NNS types))
                            (PP (IN of)
                              (NP (NN cancer)))))))))
                (, ,)
                (CC and)
                (SBAR (IN after)
                  (S
                    (NP (NN diagnosis))
                    (VP (VBD was)
                      (VP (VBN confirmed)
                        (PP (IN as)
                          (NP
                            (NP (DT a) (NN carrier))
                            (PP (IN of)
                              (NP
                                (NP (DT a) (JJ Q1200X) (NN mutation))
                                (PP (IN in)
                                  (NP (DT the) (NNP BRCA1) (NN gene)))))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (ADJP (NN vitro)))
    (NP
      (NP (NN analysis))
      (PP (IN of)
        (NP (PRP$ her) (JJ normal) (NN breast) (NN tissue))))
    (VP (VBD showed)
      (NP (DT no) (NNS differences))
      (PP (IN in)
        (NP
          (NP (NN growth) (NN rate)
            (CC or)
            (NN differentiation) (NN potential))
          (PP (IN from)
            (NP (JJ disease-free) (NNS controls))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (NNP Analysis))
        (PP (IN of)
          (NP (JJ cultured) (NN blood) (NN lymphocyte)
            (CC and)
            (NN breast) (NN epithelial) (NN cell) (NNS samples)))
        (PP (IN with)
          (NP (DT the) (JJ unscheduled) (NN DNA) (NN synthesis))))
      (PRN (-LRB- -LRB-)
        (NP (NNP UDS))
        (-RRB- -RRB-)))
    (ADVP (RB assay))
    (VP (VBD revealed)
      (NP (DT no) (NN deficiency))
      (PP (IN in)
        (NP (NNP NER))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Conclusion))
    (: :)
    (S
      (S
        (PP (IN As)
          (NP
            (NP (JJ new) (NN breast) (NN cancer) (NN screening) (NNS methods))
            (VP (VBN become)
              (S
                (ADJP
                  (ADJP (JJ available))
                  (CC and)
                  (ADJP (NN cost) (JJ effective)))))))
        (, ,)
        (NP
          (NP (NNS patients))
          (PP (JJ such) (IN as)
            (NP (DT this) (NN one))))
        (VP (MD will)
          (VP (VB constitute)
            (NP
              (NP (DT an) (VBG increasing) (NN proportion))
              (PP (IN of)
                (NP (DT the) (NN incident) (NN population)))))))
      (, ,) (IN so)
      (S
        (NP (PRP it))
        (VP (VBZ is)
          (ADJP (JJ important)
            (S
              (VP (TO to)
                (VP (VB determine)
                  (SBAR (IN whether)
                    (S
                      (NP (PRP they))
                      (VP (VBP differ)
                        (PP (IN from)
                          (NP
                            (NP (JJ current) (NNS patients))
                            (PP (IN in)
                              (NP (DT any)
                                (ADJP (RB clinically) (JJ important))
                                (NNS ways)))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN Despite)
      (NP
        (NP
          (NP (PRP$ her) (NN status))
          (PP (IN as)
            (NP (DT a) (NNP BRCA1) (NN mutation) (NN carrier))))
        (, ,)
        (CC and)
        (NP (PRP$ her) (JJ mammographically) (JJ dense) (NN breast) (NN tissue))))
    (, ,)
    (NP (PRP we))
    (VP (VBD did) (RB not)
      (VP (VB find)
        (NP (JJ increased) (NN cell) (NN proliferation)
          (CC or)
          (NN deficient) (NN differentiation) (NN potential))
        (PP (IN in)
          (NP (NN breast) (NN epithelial) (NNS cells)))
        (PP (IN from)
          (NP
            (NP (DT this) (NN patient))
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (MD might)
                  (VP (VB have)
                    (VP (VBN contributed)
                      (PP (TO to)
                        (NP (PRP$ her) (NN cancer) (NN susceptibility))))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP (NNP NER) (NN deficiency))
        (VP (VBZ has)
          (VP (VBN been)
            (VP (VBN demonstrated)
              (ADVP (RB repeatedly))
              (PP (IN in)
                (NP (NN blood) (NNS samples)))
              (PP (IN from)
                (NP (JJ sporadic) (NN breast) (NN cancer) (NNS patients))))))))
    (, ,)
    (NP
      (NP (NN analysis))
      (PP (IN of)
        (NP (NN blood))))
    (VP (VBD cultured)
      (SBAR
        (S
          (NP
            (NP (NNS lymphocytes)
              (CC and)
              (NN breast) (NN epithelial) (NNS cells))
            (PP (IN for)
              (NP (DT this) (NN patient))))
          (VP (VBZ proves)
            (ADVP (RB definitively))
            (SBAR (IN that)
              (S
                (NP
                  (NP (NN heterozygosity))
                  (PP (IN for)
                    (NP
                      (NP (NN inactivation))
                      (PP (IN of)
                        (NP (NNP BRCA1))))))
                (VP (VBZ does) (RB not)
                  (ADVP (RB intrinsically))
                  (VP (VB confer)
                    (NP
                      (NP (DT this) (NN type))
                      (PP (IN of)
                        (NP (JJ genetic) (NN instability))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS data))
    (VP (VBP suggest)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN mechanism))
            (PP (IN of)
              (NP
                (NP (JJ genomic) (NN instability))
                (VP (VBG driving)
                  (NP (DT the)
                    (ADJP (JJ carcinogenic))
                    (NN process))))))
          (VP (MD may)
            (VP (VB be)
              (ADJP (RB fundamentally) (JJ different))
              (PP (IN in)
                (NP
                  (ADJP (JJ hereditary)
                    (CC and)
                    (JJ sporadic))
                  (NN breast) (NN cancer)))
              (, ,)
              (S
                (VP (VBG resulting)
                  (PP (IN in)
                    (NP
                      (NP (JJ different) (JJ genotoxic) (NNS susceptibilities))
                      (, ,)
                      (NP (NN oncogene) (NNS mutations))
                      (, ,)
                      (CC and)
                      (NP (DT a) (JJ different) (JJ molecular) (NNS pathogenesis)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBN Background)
        (NP
          (NP (DT A) (NN reduction))
          (PP (IN in)
            (NP (NN breast) (NN cancer) (NN mortality))))))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN observed)
          (PP (IN in)
            (NP
              (NP (JJ recent) (NNS years))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBZ has)
                    (VP (VBN been)
                      (VP
                        (ADVP (RB partially))
                        (VBN attributed)
                        (PP (TO to)
                          (NP
                            (NP (DT the) (JJ widespread) (NN adoption))
                            (PP (IN of)
                              (S
                                (VP (VBG screening)
                                  (ADVP (RB mammography))
                                  (NP
                                    (QP (CD -LSB-) (CD 1))
                                    (NNS -RSB-)))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Traditional) (NN screening) (NN mammography))
    (, ,)
    (ADVP (RB however))
    (, ,)
    (VP (VBZ fails)
      (S
        (VP (TO to)
          (VP (VB detect)
            (NP
              (NP (CD 15) (NN %))
              (PP (IN of)
                (NP
                  (NP (NN incident) (NNS cancers))
                  (VP (VBG -LSB-)
                    (NP
                      (QP (CD 2) (CD -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (ADJP (NNP New) (, ,) (JJ complementary))
      (NN imaging) (NNS techniques))
    (VP (VBP are)
      (ADVP (RB therefore))
      (PP (IN under)
        (NP
          (NP (NN development))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (MD may)
                (VP (VB increase)
                  (NP
                    (NP (DT the) (NN accuracy))
                    (PP (IN of)
                      (NP (JJ primary) (NN screening)))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD performed)
      (NP (DT a) (JJ small) (NN study))
      (S
        (VP (TO to)
          (VP (VB validate)
            (NP
              (NP (DT the) (NN use))
              (PP (IN of)
                (NP (JJ low) (NN power) (JJ magnetic) (NN resonance) (NN imaging)))
              (PRN (-LRB- -LRB-)
                (NP (NNP MRI))
                (-RRB- -RRB-)))
            (S
              (VP
                (VP (TO to)
                  (ADVP (RB prospectively))
                  (VP (VB detect)
                    (NP
                      (NP (NN breast) (NNS alterations))
                      (CC and)
                      (NP (NN malignancy)))))
                (CC and)
                (VP (TO to)
                  (VP (VB determine)
                    (NP
                      (NP (DT the) (NN feasibility))
                      (PP (IN of)
                        (S
                          (VP (VBG applying)
                            (NP (DT this) (NN technique))
                            (PP (TO to)
                              (NP
                                (NP (DT a) (JJ high-risk) (NN population))
                                (VP (VBG -LSB-)
                                  (NP
                                    (QP (CD 3) (CD -RSB-))))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBP present)
      (ADVP (RB here))
      (NP
        (NP (DT a) (NN subject))
        (PP (IN from)
          (SBAR
            (WHNP
              (WHNP (WDT that) (NN study))
              (NP (WP$ whose) (JJ early) (NN stage)))
            (S
              (NP (NN tumor))
              (VP (VBD was) (RB not)
                (ADJP (JJ detectable)
                  (PP (IN by)
                    (NP (NN mammography))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN patient))
    (VP (VBD was)
      (VP (VBN enrolled)
        (PP (IN in)
          (NP (DT the) (NN screening) (NN study)))
        (PP (JJ due) (TO to)
          (NP
            (NP (PRP$ her) (NN family) (NN history))
            (PP (IN of)
              (NP (NN breast)
                (CC and)
                (JJ other) (NNS neoplasias)))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP (NN tumor) (NN diagnosis)))
    (, ,)
    (NP (PRP she))
    (VP (VBD was)
      (VP (VBN determined)
        (S
          (VP (TO to)
            (VP (VB be)
              (ADJP (JJ heterozygous)
                (PP (IN for)
                  (NP
                    (NP (DT a) (JJ putative) (VBG inactivating) (NN mutation))
                    (PP (IN in)
                      (NP (DT the) (NNP BRCA1) (NN gene)))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP she))
    (VP (VBD had)
      (NP
        (NP (JJ dense) (NN breast) (NN tissue))
        (, ,)
        (NP
          (NP (DT an) (NN impediment))
          (PP (TO to)
            (NP (NN mammography)))
          (SBAR
            (WHNP (WDT that))
            (S
              (VP (VBZ is)
                (PP (IN in)
                  (NP (PRP itself)))
                (NP
                  (NP (DT a) (NN risk) (NN factor))
                  (PP (IN for)
                    (NP (NN breast) (NN cancer)
                      (QP (CD -LSB-) (CD 4))
                      (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Breast) (NN development)
      (CC and)
      (NN lactational) (NNS differentiation))
    (ADVP (RB also))
    (VP (VBP appear)
      (S
        (VP (TO to)
          (VP
            (ADVP (RB individually))
            (VB modify)
            (NP
              (NP (NN breast) (NN cancer) (NN risk))
              (, ,)
              (PP (IN with)
                (NP
                  (NP (JJ early) (NN term) (NN pregnancy))
                  (VP (VBG conferring)
                    (NP (DT a) (JJ persistent) (JJ protective) (NN effect))
                    (S
                      (VP (VBG -LSB-)
                        (NP (CD 5) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Exposure))
      (PP (TO to)
        (NP (JJ ionizing) (NN radiation))))
    (, ,)
    (SBAR (IN while)
      (S
        (NP (DT a) (NN lifetime))
        (VP (NN risk)
          (NP
            (NP (NN factor))
            (PP (IN for)
              (NP (NN breast) (NN cancer)))))))
    (, ,)
    (VP (VBZ appears)
      (S
        (VP (TO to)
          (VP (VB be)
            (ADJP
              (ADJP (RBR more) (JJ dangerous))
              (SBAR
                (WHADVP (WRB when))
                (S
                  (NP (PRP it))
                  (VP (VBZ occurs)
                    (PP (IN during)
                      (NP
                        (NP (NN alveolar) (NN differentiation))
                        (PP (IN of)
                          (NP
                            (NP (DT the) (NN breast))
                            (PP (IN at)
                              (NP (JJ adolescence) (NNP -LSB-) (CD 6) (NNS -RSB-)))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (VBG Using)
        (NP
          (NP (DT a) (JJ novel) (NN tissue) (NN engineering) (NN system))
          (VP (VBG -LSB-)
            (NP (CD 7) (NNS -RSB-))))))
    (, ,)
    (NP (PRP we))
    (ADVP (RB therefore))
    (VP (VBD examined)
      (NP
        (NP (DT the) (NN growth)
          (CC and)
          (NN differentiation))
        (PP (IN of)
          (NP (JJ normal) (NN breast) (NN epithelial) (NNS samples))))
      (PP (IN from)
        (NP
          (NP (DT this) (NN patient))
          (PP (IN via)
            (NP (JJ live-cell) (NN imaging))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP BRCA1) (NNP hereditary) (NN breast) (NN cancer) (NN gene))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB be)
                (VP (VBN involved)
                  (PP (IN in)
                    (NP
                      (NP (NNP DNA) (RB double) (JJ strand) (NN break) (NN repair))
                      (VP (VBG -LSB-)
                        (NP (CD 8,9) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP DNA) (NN repair) (NNS defects))
      (VP (VBP have)
        (ADVP (RB also))
        (VP (VBN been)
          (VP (VBN identified)
            (PP (IN in)
              (NP
                (NP (DT the) (JJ peripheral) (NN blood) (NNS cells))
                (PP (IN of)
                  (NP (JJ sporadic) (NN breast) (NN cancer) (NNS patients)))))
            (S
              (VP (VBG -LSB-)
                (NP (CD 10-13) (NNS -RSB-))))))))
    (, ,)
    (CC but)
    (S (, ,)
      (PP (IN in)
        (NP (DT this) (NN case)))
      (, ,)
      (NP (PRP it))
      (VP (VBZ seems)
        (S
          (VP (TO to)
            (VP (VB involve)
              (NP
                (NP (DT a) (JJ different) (NN pathway))
                (PP (IN of)
                  (NP
                    (NP (NN DNA) (NN repair))
                    (, ,)
                    (NP (JJ nucleotide) (NN excision) (NN repair))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP NER))
                      (-RRB- -RRB-))
                    (NP (NNP -LSB-) (NNP 14-16) (NNP -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBP have)
      (VP (VBN extended)
        (NP
          (NP (DT this) (NN observation))
          (PP (IN of)
            (NP (NNP NER) (NN deficiency))))
        (PP (TO to)
          (NP
            (NP
              (NP (DT the) (NN tumor))
              (NP (PRP itself)))
            (, ,)
            (CONJP (RB as) (RB well) (IN as))
            (NP
              (NP (DT the) (JJ adjoining) (JJ non-diseased) (JJ normal) (NN breast) (NN tissue))
              (NP
                (QP (CD -LSB-) (CD 17))
                (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP NER))
    (VP (VBZ is)
      (NP
        (NP (DT a) (JJ complex) (NN pathway))
        (PP (IN of)
          (NP
            (NP (NN DNA) (NN repair) (NNP -LSB-) (CD 18) (NNP -RSB-))
            (VP
              (ADVP (RB normally))
              (VBN associated)
              (PP (IN with)
                (NP
                  (NP (NN removal))
                  (PP (IN of)
                    (NP
                      (NP (JJ pyrimidine-pyrimidine) (JJ intrastrand) (NNS crosslinks))
                      (PRN (-LRB- -LRB-) (`` ``)
                        (NP (NNS dimers))
                        ('' '') (-RRB- -RRB-))
                      (VP (VBN caused)
                        (PP (IN by)
                          (NP (NN exposure)))
                        (PP (TO to)
                          (NP (NNP UV) (NN light)))))))))))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP (NNP NER) (NN deficiency))
      (VP (VBZ is)
        (NP
          (NP (DT the) (NN basis))
          (PP (IN of)
            (NP
              (NP (JJ hereditary) (NN xeroderma) (NN pigmentosum))
              (PRN (-LRB- -LRB-)
                (NP (NNP XP))
                (-RRB- -RRB-)))))))
    (VP (VBZ -LSB-))
    (NP
      (NP (CD 19) (NNS -RSB-))
      (, ,)
      (NP
        (NP (DT a) (NN disease))
        (PP (IN with)
          (NP
            (NP (DT a) (JJ 1200-fold) (NN increase))
            (PP (IN in)
              (NP
                (NP (NN incidence))
                (PP (IN of)
                  (NP (NN skin) (NN cancer) (NNP -LSB-) (NNP 20) (NNP -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN signal))
        (PP (IN for)
          (NP
            (NP (NN activation))
            (PP (IN of)
              (NP (DT the) (NNP NER) (NN pathway))))))
      (VP (VBZ is)
        (ADVP (RB actually))
        (ADJP (RB very) (JJ general))))
    (: ;)
    (S
      (NP
        (NP (DT any) (NN lesion))
        (VP (VBG causing)
          (NP
            (NP (DT a) (NN distortion))
            (PP (IN in)
              (NP (DT the) (NNP DNA) (NN helix))))
          (, ,)
          (PP (VBG including)
            (NP
              (NP (NNS crosslinks))
              (VP
                (VP (VBN caused)
                  (PP (IN by)
                    (NP
                      (NP (JJ oxidative) (NNS radicals))
                      (, ,)
                      (NP
                        (NP (JJ certain) (NNS types))
                        (PP (IN of)
                          (NP
                            (NP (NNS mismatches))
                            (PRN (-LRB- -LRB-)
                              (NP (JJ purine-purine)
                                (CC or)
                                (JJ pyrimidine-pyrimidine))
                              (-RRB- -RRB-))))))))
                (CC and)
                (ADVP (RB so))
                (VP (VBN called)
                  (NP
                    (NP (`` ``) (JJ bulky) ('' '') (NNS adducts))
                    (VP (VBN caused)
                      (PP (IN by)
                        (NP
                          (NP (NN phase) (NN I) (NN metabolism))
                          (PP (IN of)
                            (NP (JJ polyaromatic) (NNS hydrocarbons)))))))))))))
      (VP (VBZ -LSB-)
        (NP (CD 21) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ has)
      (ADVP (RB recently))
      (VP (VBN been)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP (NNP BRCA1) (NN expression))
              (VP (MD can)
                (VP (VB enhance)
                  (NP (NNP NER) (NN activity))))))
          (, ,)
          (SBAR (IN although)
            (S
              (NP (DT this) (NN analysis))
              (VP (VBD was) (RB not)
                (VP (VBN performed)
                  (PP (IN in)
                    (NP (NN breast) (NNS cells)))
                  (S
                    (VP (VBG -LSB-)
                      (NP (CD 22,23) (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB therefore))
    (VP (VBD applied)
      (NP
        (NP (DT the)
          (ADJP (JJ functional) (JJ unscheduled))
          (NN DNA) (NN synthesis))
        (PRN (-LRB- -LRB-)
          (NP (NNP UDS))
          (-RRB- -RRB-)))
      (PP
        (ADVP (RB assay))
        (IN for)
        (NP (NNP NER) (NN capacity)))
      (PP (TO to)
        (NP
          (NP (JJ multiple) (NNS samples))
          (PP (IN of)
            (NP
              (NP (JJ normal) (NN tissue))
              (PP (IN from)
                (NP (DT this) (NN patient)))))))
      (, ,)
      (S
        (VP (TO to)
          (VP (VB determine)
            (SBAR (IN whether)
              (S
                (NP
                  (NP (NN haploinsufficiency))
                  (PP (IN for)
                    (NP (NNP BRCA1))))
                (VP (VBD was)
                  (NP
                    (NP (DT a) (NN mechanism))
                    (PP (IN of)
                      (NP (NNP NER) (NN deficiency)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN developed)
          (NP (DT a) (NN method))
          (PP (TO to)
            (NP (JJ reliably) (NN culture) (JJ non-diseased) (NN breast) (NN tissue)))
          (PRN (-LRB- -LRB-)
            (PP (IN with)
              (NP
                (NP (DT a) (NN success) (NN rate))
                (PP (IN of)
                  (NP (CD 100) (NN %)))))
            (-RRB- -RRB-)))))
    (CC and)
    (S
      (NP (NN breast) (NNS tumors))
      (PRN (-LRB- -LRB-)
        (PP (IN with)
          (NP
            (NP (DT a) (NN success) (NN rate))
            (PP (IN of)
              (NP (CD 85) (NN %)))))
        (-RRB- -RRB-))
      (VP (VBZ -LSB-)
        (NP (CD 7,17) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (NP (NNP Case))
    (VP (VBD presentation)
      (SBAR
        (S
          (NP (PRP We))
          (VP (VBP describe)
            (NP
              (NP (DT a) (NN breast) (NN cancer) (NN patient))
              (SBAR
                (WHNP (WP$ whose) (NNS tumor))
                (S
                  (VP (VBD was)
                    (VP (VBN detected)
                      (PP (IN by)
                        (NP (NNP MRI))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP She))
    (VP (VBD was)
      (VP (VBN enrolled)
        (PP (IN into)
          (NP
            (NP (DT a) (NN pilot) (NN screening) (NN study))
            (PP (IN of)
              (NP
                (NP (JJ low) (NN power) (NNS MRI))
                (ADJP (JJ due)
                  (PP (TO to)
                    (NP (PRP$ her) (JJ familial) (NN risk))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (PRP She))
      (VP (VBD had)
        (NP (JJ mammographically) (JJ dense) (NNS breasts))))
    (CC and)
    (S
      (NP (PRP$ her) (NN tumor))
      (VP (VBD was)
        (ADJP (JJ undetectable) (RB mammographically))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN patient))
    (VP (VBD was)
      (NP
        (NP (DT a) (JJ 35.7) (NN year) (JJ old) (NN woman))
        (SBAR
          (WHNP (WP who))
          (S
            (VP (VBD presented)
              (PP (IN with)
                (NP
                  (NP (DT a)
                    (ADJP (RB very) (JJ strong))
                    (NN family) (NN history))
                  (PP (IN of)
                    (NP (NN breast) (NN cancer)))))
              (SBAR (IN as)
                (S
                  (VP (VBN depicted)
                    (PP (IN in)
                      (NP
                        (NP
                          (QP (CD Figure) (CD 1)))
                        (, ,)
                        (CC and)
                        (NP (JJ negative)
                          (ADJP (NN physical)
                            (CC and)
                            (JJ mammographic))
                          (NN examination))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP She))
    (VP (VBD had)
      (NP
        (ADJP (RB extremely) (JJ dense))
        (NN breast) (NN tissue))
      (PP
        (ADVP (RB bilaterally))
        (IN by)
        (NP
          (ADJP (JJ mammography)
            (CONJP (RB as) (RB well) (IN as))
            (JJ fibrocystic))
          (NN breast) (NN tissue)))
      (PP (IN by)
        (NP (JJ physical) (NN examination))))
    (. .)))

(ROOT
  (S
    (NP (PRP She))
    (VP (VBD had)
      (NP
        (NP (DT no) (JJ previous) (JJ personal) (NN history))
        (PP (IN of)
          (NP
            (NP (NN breast) (NN biopsy))
            (CC or)
            (NP (JJ abnormal) (NNS mammograms))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT The) (CD 5) (NN year) (NN breast) (NN cancer))
      (VP (VBP risk)
        (PP (IN for)
          (NP (DT this) (NN patient)))
        (SBAR (IN as)
          (S
            (S
              (VP (VBN calculated)
                (PP (IN by)
                  (NP (DT the) (NNP BRCAPRO) (NN model)))))
            (VP (VBD was)
              (NP (CD 5.7) (NN %)))))))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (PRP$ her) (NN probability))
        (PP (IN of)
          (S
            (VP (VBG being)
              (NP (DT a) (NN BRCA1)
                (CC or)
                (NN BRCA2) (NN carrier))))))
      (VP (VBD was)
        (NP (CD 0.47))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP Gail) (NN model) (NN risk) (NN assessment))
    (VP (VBD was)
      (VP (VBN calculated)
        (S
          (VP (VBG using)
            (NP
              (NP (DT the) (VBG following) (NN information))
              (: :)
              (NP
                (NP
                  (NP (NNP Race-Caucasian))
                  (: ;)
                  (NP (NNS Age-35)))
                (: ;)
                (NP
                  (NP (NNP Age))
                  (PP (IN at)
                    (NP (JJ first) (NN menses-12))))
                (: ;)
                (NP
                  (NP (NNP Age))
                  (PP (IN at)
                    (NP (JJ first) (JJ live) (NNS birth-nulliparous))))
                (: ;)
                (NP
                  (NP (NNP Number))
                  (PP (IN of)
                    (NP
                      (NP (JJ first-degree) (NNS relatives))
                      (PP (IN with)
                        (NP (NN breast) (NN cancer-2))))))
                (: ;)
                (NP
                  (NP (NNP Number))
                  (PP (IN of)
                    (NP (JJ previous) (NN breast) (NNS biopsies-0))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT The) (JJ calculated) (CD 5) (NN year) (NN Gail) (NN risk))
      (VP (VBD was)
        (NP (CD 1.0) (NN %))))
    (CC and)
    (S
      (NP (PRP$ her) (NN lifetime) (NN risk))
      (VP (VBD was)
        (NP (CD 31.3) (NN %))))
    (. .)))

(ROOT
  (S
    (PP (VBG Following)
      (NP (JJ genetic) (NN counseling)))
    (, ,)
    (NP (DT the) (NN patient))
    (VP (VBD elected)
      (S
        (VP (TO to)
          (VP (VB undergo)
            (NP
              (NP (NN DNA) (NN sequencing))
              (PP (IN of)
                (NP (DT the) (NNP BRCA1)
                  (CC and)
                  (NNP BRCA2) (NNS genes)))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBD revealed)
                    (NP (DT a) (JJ Q1200X) (NN truncation) (NN mutation))
                    (PP (IN in)
                      (NP
                        (NP (CD one))
                        (PP (IN of)
                          (NP (PRP$ her) (JJ BRCA1) (NNS alleles)))))))))))))
    (. .)))

(ROOT
  (NP
    (NP (DT The) (NNP C))
    (PP (TO to)
      (NP (NNP T) (NN mutation)))
    (PP (IN at)
      (NP (NN codon) (CD 1200)))
    (PP (IN in)
      (NP (JJ exon) (CD 11) (NNS results)))
    (PP (IN in)
      (NP (DT the) (NN change)))
    (PP (IN of)
      (NP (DT the) (JJ amino) (NN acid) (NN glutamine)))
    (PP (TO to)
      (NP (DT a) (NN stop) (NN codon)))
    (PP (IN with)
      (S
        (VP (VBG resulting)
          (NP
            (NP (NN protein) (NN truncation)
              (CC and)
              (NN loss))
            (PP (IN of)
              (NP (NN function)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Exon) (CD 11))
    (VP
      (VP (VBZ is)
        (NP
          (NP (DT the) (JJS largest) (NN exon))
          (PP (IN in)
            (NP (NNP BRCA1)))))
      (CC and)
      (VP (VBZ has)
        (NP
          (NP (DT the) (JJS highest) (NN frequency))
          (PP (IN of)
            (NP (VBN reported) (NNS mutations))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP Q1200X) (NN mutation))
    (VP (VBZ has)
      (VP (VBN been)
        (VP
          (ADVP (RB independently))
          (VBN observed)
          (NP
            (QP (JJ several) (NNS times))
            (JJ -LSB-) (CD 24) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ bilateral) (NN screening) (NN mammogram))
    (VP (VBD was)
      (PP (VBN compared)
        (PP (TO to)
          (NP
            (NP (JJ previous) (NNS films))
            (PP (IN from)
              (NP (DT another) (NN hospital)))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN breast) (NN tissue))
    (VP (VBD was)
      (VP (VBN described)
        (PP (IN as)
          (NP (JJ heterogeneously) (NNS dense)))
        (, ,)
        (S
          (ADVP (RB thus))
          (VP (VBG lowering)
            (NP (DT the) (NN sensitivity))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (EX There))
      (VP (VBD were)
        (NP
          (NP (DT no) (NNS masses))
          (, ,)
          (NP (JJ significant) (NNS calcifications))
          (CC or)
          (NP (JJ other) (NNS findings)))))
    (CC and)
    (S
      (NP (DT the) (NN mammogram))
      (VP (VBD was)
        (VP (VBN interpreted)
          (PP (IN as)
            (NP (JJ negative) (NN bilaterally))))))
    (. .)))

(ROOT
  (S
    (NP (DT A) (JJ one-year) (NN follow-up))
    (VP (VBD was)
      (VP (VBN recommended)))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT The) (NN patient))
      (VP (VBD was) (RB then)
        (ADJP (RB MRI) (JJ scanned)
          (SBAR (IN as)
            (S
              (ADVP (RB previously))
              (VP (VBD described)
                (NP
                  (QP (CD -LSB-) (CD 3))
                  (NNS -RSB-))
                (, ,)
                (PP (IN with)
                  (NP (NN pre)))))))))
    (: -)
    (CC and)
    (S
      (NP (JJ post-gadolinium) (NN enhancement) (NNS images))
      (VP (VBG evaluating)
        (NP (DT both) (NNS breasts))
        (ADVP (RB simultaneously))
        (PP (IN in)
          (NP (DT the) (JJ axial) (NN plane)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ upper-outer) (JJ left) (NN breast)))
    (NP (EX there))
    (VP (VBD was)
      (NP
        (NP
          (NP (DT a) (JJ small))
          (PRN (-LRB- -LRB-)
            (NP
              (QP (RB approximately) (CD 1) (CD cm)))
            (-RRB- -RRB-)))
        (, ,)
        (NP (NN round))
        (, ,)
        (VP (VBN well-demarcated)
          (S
            (VP (VBG enhancing)
              (NP (NN lesion)))))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN lesion))
    (VP (VBD was)
      (VP (VBN seen)
        (PP (IN on)
          (NP (PDT both)
            (NP
              (NP (DT the) (JJ initial) (NN delay))
              (PP (IN after)
                (NP (NN contrast) (NN injection))))
            (CC and)
            (NP
              (NP (DT the) (JJ delayed) (NN contrast))
              (VP (VBN enhanced)
                (NP (NN subtraction) (NNS images))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN lesion))
    (VP (VBD appeared)
      (S
        (VP (TO to)
          (VP (VB accumulate)
            (NP (NN contrast))
            (PP (TO to)
              (NP
                (NP (DT a) (JJR greater) (NN extent))
                (PP (IN on)
                  (NP
                    (NP (DT the) (JJ delayed) (NN subtraction) (NNS images))
                    (PP (IN with)
                      (NP
                        (NP (DT an) (JJ additional) (NN lesion))
                        (ADVP (JJ adjacent)
                          (PP (TO to)
                            (NP (DT the) (JJ first))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (JJ medial) (NN aspect))
        (PP (IN of)
          (NP (DT the) (JJ mid) (NN right) (NN breast)))))
    (, ,)
    (NP (EX there))
    (VP (VBD were)
      (NP
        (NP (JJ several) (JJ small) (NN punctate) (NNS areas))
        (PP (IN of)
          (NP
            (NP (NN enhancement))
            (PP (IN on)
              (NP (PDT both) (DT the) (JJ immediate)
                (CC and)
                (JJ delayed) (NN subtraction) (NNS views)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Also))
    (PP (IN in)
      (NP
        (NP (DT the) (JJ right) (NN breast))
        (PP (RB just) (IN above)
          (NP
            (NP (DT the) (JJ nipple) (NN level))
            (ADJP (JJ medial)
              (CC and)
              (JJ close))
            (PP (TO to)
              (NP (DT the) (NN chest) (NN wall)))))))
    (NP (DT an) (JJ additional) (NN enhancing) (NN lesion))
    (VP (VBD was)
      (VP (VBN seen)))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN lesion))
    (VP (VBD was)
      (NP
        (NP
          (NP
            (QP (RB approximately) (CD 1.5))
            (NN cm))
          (, ,)
          (NP (NN round))
          (, ,))
        (ADJP (JJ well-demarcated)
          (CC and)
          (JJ continued)))
      (PP (TO to)
        (NP
          (NP (JJ accumulate) (NN contrast))
          (PP (IN on)
            (NP (DT the) (JJ delayed) (NN subtraction) (NNS images))))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN lesion))
    (VP (VBD appeared)
      (S
        (VP (TO to)
          (VP (VB have)
            (NP (DT a) (JJ small) (JJ non-enhancing) (NN septation))))))
    (. .)))

(ROOT
  (S
    (PP (IN Under)
      (NP (NN ultrasound)))
    (, ,)
    (NP
      (NP (DT the) (NN lesion))
      (PP (IN of)
        (NP
          (NP (NN concern))
          (PP (IN in)
            (NP (DT the) (JJ left) (NN breast))))))
    (VP (VBD was)
      (VP
        (VP (VBN identified)
          (CC and)
          (VBN biopsied))
        (, ,)
        (CONJP (RB as) (RB well) (IN as))
        (VP
          (ADVP (CD one))
          (VBN lesion)
          (PP (IN in)
            (NP
              (NP (DT the) (JJ right) (NN breast))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (CD 2))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ core) (NN biopsy))
      (PP (IN of)
        (NP (DT the) (JJ left) (NN breast))))
    (VP (VBD revealed)
      (S
        (VP (VBG infiltrating)
          (NP (JJ ductal) (NN carcinoma))
          (PP (IN in)
            (NP
              (NP
                (NP (CD 2))
                (PP (IN of)
                  (NP (CD 5) (NN core) (NNS fragments))))
              (: ;) (JJ high)
              (NP (JJ nuclear) (NN grade))))))
      (, ,)
      (PP (IN with)
        (NP
          (NP (DT no) (JJ lymphatic) (NN invasion))
          (VP (VBN seen)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ core) (NN biopsy))
      (PP (IN of)
        (NP (DT the) (JJ right) (NN breast))))
    (VP (VBD demonstrated)
      (NP
        (ADJP
          (ADJP (JJ benign) (JJ pathology))
          (PRN (, ,)
            (ADVP (RB specifically))
            (, ,)))
        (NN fibrosis))
      (PP (IN with)
        (NP (JJ focal) (JJ ductal) (JJ epithelial) (NN hyperplasia))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (FRAG
        (NP
          (NP (DT a) (JJ surgical) (NN candidate))
          (PP (IN for)
            (NP (NN lumpectomy)
              (CC and)
              (NN radiation))))))
    (, ,)
    (NP (DT the) (NN patient))
    (VP (VBD chose)
      (S
        (VP (TO to)
          (VP
            (VP (VB undergo)
              (NP
                (NP (JJ left) (VBN modified) (JJ radical) (NN mastectomy))
                (PP (IN with)
                  (NP (JJ left) (JJ axillary) (NN lymph) (NN node) (NN dissection)))))
            (CC and)
            (VP (VB contralateral)
              (NP
                (NP (JJ prophylactic) (JJ total) (NN mastectomy))
                (PP (RB because) (IN of)
                  (NP (PRP$ her) (JJ genetic) (NN risk) (NN status)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN pathology))
      (PP (IN in)
        (NP (DT the) (JJ left) (NN breast))))
    (VP (VBD was)
      (ADJP (JJ consistent)
        (PP (IN with)
          (NP
            (NP (DT the) (NN imaging)
              (CC and)
              (NN core) (NN biopsy))
            (PP (IN in)
              (NP (NN size)
                (CC and)
                (NN description)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (JJ Tumor) (NN size))
      (VP (VBD was)
        (NP
          (NP (CD 8) (NN mm))
          (PP (IN in)
            (NP (JJS greatest) (NN dimension))))))
    (, ,)
    (S
      (NP (JJ nuclear) (NN grade) (NNP III) (, ,) (NNP ER/PR)
        (CC and)
        (NNS Her2/neu))
      (ADJP (JJ negative)))
    (, ,)
    (CC and)
    (S
      (NP
        (NP (DT the) (JJ nodal) (NN status))
        (PRN (-LRB- -LRB-)
          (NP (CD 0/4))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (ADJP (JJ negative))
        (PRN (-LRB- -LRB-)
          (NP (NN stage) (NNS TIaN0M0))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN patient))
    (VP
      (VP (VBD underwent)
        (NP
          (NP (CD 4) (NNS cycles))
          (PP (IN of)
            (NP (NN chemotherapy)))))
      (CC and)
      (VP (VBZ has)
        (VP (VBN been)
          (ADVP (RB reportedly))
          (ADJP (JJ healthy)
            (PP (IN since))))))
    (. .)))

(ROOT
  (S
    (PP (IN Because)
      (PP (IN of)
        (NP (DT the) (JJ positive) (JJ BRCA1) (NN mutation) (NNS results))))
    (, ,)
    (NP (PRP she))
    (ADVP (RB subsequently))
    (VP (VBD underwent)
      (NP (JJ prophylactic) (JJ bilateral) (NN salpingo-oophorectomy)))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (NN number))
      (PP (IN of)
        (NP (NN life) (NN history) (NNS factors))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN associated)
          (PP (IN with)
            (NP
              (NP (NN breast) (NN cancer) (NN incidence))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBP are)
                    (ADVP (RB widely))
                    (VP (VBN interpreted)
                      (PP (IN as)
                        (S
                          (VP (VBG representing)
                            (NP
                              (NP (NN lifetime) (NN exposure))
                              (PP (IN of)
                                (NP (DT the) (NN breast) (NN tissue))))
                            (PP (TO to)
                              (NP
                                (NP (JJ estrogen-induced) (NNS mitogenesis))
                                (VP (VBG -LSB-)
                                  (NP (CD 25) (NNS -RSB-)))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT An) (JJ alternative) (NN interpretation))
      (, ,)
      (VP (VBN based)
        (PP (IN on)
          (NP (JJ epithelial) (NN cell) (NN differentiation))))
      (, ,))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ lactational) (NN differentiation))
            (, ,)
            (PP (JJ such) (IN as)
              (S
                (VP (VBG occurs)
                  (PP (IN during)
                    (NP (NN term) (NN pregnancy))))))
            (, ,))
          (VP (VBZ confers)
            (NP (NN resistance))
            (S
              (VP (TO to)
                (VP (VB carcinogenesis)
                  (NP
                    (QP (CD -LSB-) (CD 26,27))
                    (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBP have)
      (VP (VBN developed)
        (NP
          (NP (DT a) (JJ novel) (JJ human)
            (ADJP
              (ADJP (RB mammary) (JJ epithelial))
              (PRN (-LRB- -LRB-)
                (NP (NNP HME))
                (-RRB- -RRB-)))
            (NN tissue) (NN engineering) (NN system))
          (SBAR
            (WHADVP (WRB wherein))
            (S
              (NP
                (NP (JJ many) (NNS aspects))
                (PP (IN of)
                  (NP (JJ organotypic) (NN differentiation))))
              (VP (VBP are)
                (VP (VBN reiterated)
                  (PP (IN in)
                    (NP (NNP vitro) (NNP -LSB-) (CD 28) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT this) (NN system)))
    (, ,)
    (NP (NN breast) (NN epithelial) (NNS cells))
    (ADVP (RB initially))
    (VP
      (VP (VB retain)
        (NP (JJ cell-to-cell) (NN contact))
        (SBAR (IN while)
          (S
            (NP (PRP they))
            (VP (VBP proliferate)))))
      (, ,) (RB then)
      (VP (VB undergo)
        (NP (DT an) (JJ architectural) (NN reorganization))
        (, ,)
        (S
          (ADVP (RB first))
          (VP (TO to)
            (VP (VB form)
              (NP
                (NP (JJ three-dimensional) (NNS mammospheres))
                (, ,)
                (CC and)
                (ADVP (RB later))
                (NP
                  (NP (JJ vast) (NNS networks))
                  (PP (IN of)
                    (NP (JJ branching) (NN ductal)
                      (CC and)
                      (NN lobular) (NNS structures))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Tumor))
      (CC and)
      (NP (DT some) (JJ pre-neoplastic) (NNS samples)))
    (VP (VBP fail)
      (S
        (VP (TO to)
          (VP (VB form)
            (NP (JJ such) (NN architecture))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Normal) (NN tissue))
      (PP (IN from)
        (NP (DT this) (NN patient)))
      (, ,)
      (SBAR
        (WHNP (WP who))
        (S
          (VP
            (VP (VBZ is)
              (NP (PDT both) (DT a) (JJ BRCA1) (NN mutation) (NN carrier)))
            (CC and)
            (VP (VBZ has)
              (NP (JJ dense) (NNS breasts))))))
      (, ,))
    (VP (VBD was)
      (VP (VBN evaluated)
        (S
          (VP (TO to)
            (VP (VB determine)
              (SBAR (IN whether)
                (S
                  (NP
                    (NP (DT either))
                    (PP (IN of)
                      (NP (DT these) (NNS factors))))
                  (VP (VBD affected)
                    (NP
                      (NP (IN de) (JJ novo) (NN differentiation))
                      (PP (IN in)
                        (NP (DT this) (NN system))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD Four) (JJ discrete) (NNS pieces))
      (PP (IN of)
        (NP (JJ fresh) (NN tissue))))
    (VP (VBD were)
      (VP (VBN provided)
        (PP (IN for)
          (NP (JJ live-cell) (NN analysis)))
        (PP (IN from)
          (NP
            (NP (DT each))
            (PP (IN of)
              (NP
                (NP (DT the) (NN patient) (POS 's))
                (ADJP (JJ ipsilateral)
                  (CC and)
                  (JJ contralateral))
                (NNS breasts)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (NN case))
        (PP (IN of)
          (NP (DT the) (JJ ipsilateral) (NN breast)))))
    (, ,)
    (NP (DT this) (NN tissue))
    (VP (VBD was)
      (VP (VBN provided)
        (PP (IN at)
          (S
            (VP (VBG increasing)
              (NP (NN distance))
              (PP (IN from)
                (NP
                  (NP (DT the) (NN tumor) (NN margin))
                  (PP (IN in)
                    (NP (CD 1) (NN cm) (NNS increments))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT All))
      (PP (IN of)
        (NP (DT these) (JJ normal) (NNS samples))))
    (VP
      (VP (VBD attached))
      (CC and)
      (VP
        (VP (VBD grew)
          (PP (IN in)
            (NP (PRP$ our) (NN culture) (NN system))))
        (CC and)
        (VP (VBD were)
          (VP (VBN examined)
            (PP (IN for)
              (NP (JJ cell-to-cell) (NNS interactions)
                (CC and)
                (NN morphology)))
            (PP (IN over)
              (NP
                (NP (DT a) (NN period))
                (PP (IN of)
                  (NP (CD one)))))
            (NP (NN month))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (NN context))
        (PP (IN of)
          (NP
            (NP (NN breast) (NN reduction) (NN explant) (NNS cultures))
            (PP (IN from)
              (NP
                (NP (CD 22) (NNS patients))
                (PP (IN with)
                  (NP (DT no) (NN breast) (NN disease)))))))))
    (, ,)
    (NP (DT these) (JJ patient) (NNS samples))
    (VP (VBD manifested)
      (NP
        (NP (JJ typical) (NNS mixtures))
        (PP (IN of)
          (NP
            (ADJP (JJ fibroblastic)
              (CC and)
              (JJ epithelial))
            (NNS cells)))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (JJ several) (NNS days))
        (PP (IN in)
          (NP
            (NP (NN culture))
            (PP (IN without)
              (NP (NN passaging)))))))
    (, ,)
    (S
      (NP (DT the) (JJ epithelial) (NNS cells))
      (VP (VBD began)
        (S
          (VP (TO to)
            (VP (VB self-organize))))
        (, ,)
        (S
          (ADVP (RB initially))
          (VP (VBG forming)
            (NP
              (NP (JJ three-dimensional) (NNS mammospheres))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (CD 3A))
                (-RRB- -RRB-)))))))
    (, ,)
    (CC and)
    (, ,)
    (S
      (PP (IN after)
        (NP
          (NP (CD 2) (NNS weeks))
          (PP (IN in)
            (NP (NN culture)))))
      (, ,)
      (NP
        (NP
          (ADJP (RBR more) (JJ complex))
          (JJ pre-ductal) (JJ linear) (NNS columns))
        (PP (IN of)
          (NP
            (NP (JJ epithelial) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (NN Figure) (CD 3B))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN tissue) (NNS explants))
      (PP (IN from)
        (NP (DT both) (NNS breasts))))
    (VP (VBD showed)
      (NP
        (NP (JJ similar) (NNS patterns))
        (PP (IN of)
          (NP
            (NP (NN behavior))
            (PRN (-LRB- -LRB-)
              (NP (NN Figure) (CD 3))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNP Tissue))
      (VP (VBD cultured)
        (PP (IN from)
          (NP (DT a) (JJ contemporaneous) (JJ disease-free) (NN control)))))
    (CC and)
    (S
      (NP
        (NP (DT the) (JJ contralateral) (NN breast))
        (PP (IN of)
          (NP (DT a) (JJ sporadic) (NN breast) (NN cancer) (NN patient))))
      (VP (VBD showed)
        (NP
          (NP (JJ similar) (NN morphology)
            (CC and)
            (NN architecture))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNS data))
              (VP (RB not) (VBN shown)))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN suggested)
          (SBAR (IN that)
            (S
              (NP
                (NP (DT the) (NN association))
                (PP (IN between)
                  (NP
                    (NP (NN breast) (NN density)
                      (CC and)
                      (NN risk))
                    (PP (IN of)
                      (NP (NN breast) (NN cancer))))))
              (VP (VBZ is)
                (ADJP (JJ due)
                  (PP (TO to)
                    (NP
                      (NP (VBN increased) (NN cell) (NN proliferation))
                      (VP (VBG -LSB-)
                        (NP (CD 29) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD One) (NN measure))
      (PP (IN of)
        (NP (NN cell) (NN growth)
          (CC and)
          (NN viability))))
    (VP (VBZ is)
      (NP
        (NP
          (NP (DT the) (JJ S-phase) (NN index))
          (PRN (-LRB- -LRB-)
            (NP (NNP SPI))
            (-RRB- -RRB-)))
        (CC or)
        (NP
          (NP (DT the) (NN percentage))
          (PP (IN of)
            (NP
              (NP (NNS cells))
              (VP (VBG incorporating)
                (NP (JJ radiolabeled) (NN thymidine))
                (PP (IN over)
                  (NP
                    (NP (DT a) (JJ specific) (NN incubation) (NN period))
                    (PRN (-LRB- -LRB-)
                      (PP (IN in)
                        (NP
                          (NP (PRP$ our) (NN case))
                          (, ,)
                          (NP (CD 2) (NNS hours))))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT a) (JJ previous) (NN study))
        (PP (IN with)
          (NP (CD 22) (JJ normal) (NN breast) (NN reduction) (NN epithelium) (JJ -LSB-) (NNP BRE) (VBG -RSB-) (NNS cultures)))))
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ wide) (NN range))
        (PP (IN of)
          (NP (NN proliferation) (NNS rates))))
      (, ,)
      (PP (IN with)
        (NP
          (NP (NNP SPI))
          (VP (VBG ranging)
            (PP (IN from)
              (NP
                (NP (DT a) (NN low))
                (PP (IN of)
                  (NP (CD 0.2) (NN %)))))
            (PP (TO to)
              (NP
                (NP (DT a) (NN high))
                (PP (IN of)
                  (NP (CD 46.0) (NN %)))))
            (PRN (-LRB- -LRB-)
              (S
                (VP (VB mean)
                  (PP (IN of)
                    (NP
                      (NP (CD 18.3) (NNS ±))
                      (ADJP (CD 2.6) (NN %))))))
              (-RRB- -RRB-))
            (S
              (VP (VBG -LSB-)
                (NP (CD 30) (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ contemporaneous) (NN control) (NN sample))
      (PP (IN from)
        (NP (DT a) (JJ disease-free) (NN breast) (NN reduction) (NN patient))))
    (VP (VBD had)
      (NP
        (NP (DT an) (NNP SPI))
        (PP (IN of)
          (NP (CD 30.9) (NN %))))
      (, ,)
      (PP (IN at)
        (NP
          (NP (DT the) (JJR higher) (NN end))
          (PP (IN of)
            (NP (DT this) (JJ normal) (NN range))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The)
        (ADJP (JJ ipsilateral)
          (CC and)
          (JJ contralateral))
        (NN tissue) (NNS samples))
      (PP (IN from)
        (NP (DT the) (JJ hereditary) (NN breast) (NN cancer) (NN patient))))
    (VP (VBD exhibited)
      (NP
        (NP (NNP SPI))
        (PP (IN of)
          (NP
            (NP (CD 26.6) (NN %))
            (CC and)
            (NP (CD 26.2) (NN %)))))
      (, ,)
      (ADVP (RB respectively))
      (, ,)
      (S
        (VP (VBG placing)
          (NP (PRP them))
          (ADVP (IN at) (RB slightly))
          (PP (IN over)
            (NP
              (NP (DT the) (JJ 70th) (NN percentile))
              (PP (IN for)
                (NP (NN growth) (NN rate))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ contralateral) (NN sample))
      (PP (IN from)
        (NP (DT the) (JJ sporadic) (NN breast) (NN cancer) (NN patient))))
    (VP (VBD had)
      (NP
        (NP (DT an) (NNP SPI))
        (PP (IN of)
          (NP (CD 17.0) (NN %))))
      (, ,)
      (S
        (VP (VBG placing)
          (NP (PRP it))
          (ADVP (RB slightly))
          (PP (IN under)
            (NP (DT the) (JJ 50th) (NN percentile))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Thus))
    (, ,)
    (NP
      (NP (DT all))
      (PP (IN of)
        (NP (DT these) (NN breast) (NN cancer) (JJ patient) (NNS samples))))
    (VP (VBD appeared)
      (S
        (VP (TO to)
          (VP (VB grow)
            (ADVP (RB well))
            (PP (IN in)
              (NP (PRP$ our) (NN system))))))
      (, ,)
      (PP (IN with)
        (NP (NNP SPI)))
      (PP (RB well) (IN within)
        (NP
          (NP (DT the) (NN range))
          (PP (IN of)
            (NP (PRP$ our) (JJ normal) (NNS samples))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN similarity))
        (PP (IN of)
          (NP
            (NP (DT the) (NNP SPI) (NNS values))
            (PP (IN from)
              (NP
                (NP (DT the) (CD two) (NNS samples))
                (PP (IN from)
                  (NP (DT the) (NNP BRCA1) (NN mutation) (NN carrier))))))))
      (VP (VBZ does) (RB not)
        (VP (VB appear)
          (S
            (VP (TO to)
              (VP (VB be)
                (ADJP (JJ accidental))))))))
    (: ;)
    (S
      (NP
        (NP (DT the) (NNS chances))
        (PP (IN of)
          (S
            (VP (VBG selecting)
              (NP (CD two) (NNS samples))
              (PP (IN from)
                (NP
                  (NP (DT the) (JJ normal) (NN population))
                  (PP (IN with)
                    (NP (NNS values)))))))))
      (ADVP
        (ADVP (RB as) (RB close))
        (CC or)
        (ADVP (RBR closer)))
      (VP (VBZ is)
        (ADJP (RB very) (JJ small))
        (PRN (-LRB- -LRB-)
          (NP (NNP P)
            (QP (CD =) (CD 0.026)))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Peripheral) (NN blood) (NNS lymphocytes))
      (CC and)
      (NP
        (NP (JJ normal) (NN breast) (NN epithelial) (NN tissue))
        (PP (IN from)
          (NP (DT the) (JJ hereditary) (NN cancer) (NN patient)))))
    (VP (VBD were)
      (ADVP (RB then))
      (VP (VBN cultured)
        (PP (IN for)
          (NP
            (NP (NN performance))
            (PP (IN of)
              (NP
                (NP (DT the) (NNP functional) (NNP UDS) (NN assay))
                (, ,)
                (SBAR
                  (WHNP (WDT which))
                  (S
                    (VP (VBZ requires)
                      (S
                        (VP (VBG living)
                          (NP
                            (NP (NNS cells))
                            (PP (IN for)
                              (NP (JJ radiolabel) (NN incorporation))))
                          (PP (IN during)
                            (NP
                              (NP (NN DNA) (NN repair) (NN synthesis))
                              (PP (VBG following)
                                (NP (NNP UV) (NN exposure))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This))
    (ADVP (RB assay))
    (VP (VBZ is)
      (NP
        (NP (JJ diagnostic))
        (PP (IN for)
          (NP
            (NP (DT the) (VBN inherited) (JJ cancer-prone) (NN disease) (NN XP))
            (, ,)
            (SBAR
              (WHADVP (WRB where))
              (S
                (NP (PRP it))
                (VP (VBZ is)
                  (ADVP (RB usually))
                  (VP (VBN performed)
                    (PP (IN in)
                      (NP (NNS lymphocytes)
                        (CC or)
                        (NN skin) (NNS fibroblasts)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (PRP$ Our) (VBD novel) (NNP HME) (NN tissue) (VBG engineering) (NN system))
      (VP (VBZ allows)
        (S
          (NP (PRP us))
          (VP (TO to)
            (VP (VB apply)
              (NP (DT the) (NN assay))
              (PP (TO to)
                (NP (NN breast) (NN epithelial) (NNS cells))))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP we))
      (VP (VBP have)
        (ADVP (RB previously))
        (VP (VBN demonstrated)
          (ADVP (RB tissue-specificity))
          (PP (IN in)
            (NP
              (NP (DT the) (NNP NER) (NN capacity))
              (PP (IN of)
                (NP
                  (NP (DT these) (NNS cells))
                  (PP (IN in)
                    (NP (JJ normal) (NNS samples)))))))
          (PP (IN from)
            (NP
              (NP (NNS patients))
              (VP (VBG undergoing)
                (NP (NN breast) (NN reduction) (NN mammoplasty) (NNP -LSB-) (CD 30) (NNP -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Patient) (NNS data))
    (VP (VBZ is)
      (ADVP (RB therefore))
      (VP (VBN expressed)
        (ADVP (JJ relative))
        (PP (TO to)
          (NP
            (NP (DT the) (NN average))
            (PP (IN of)
              (NP (PRP$ our) (NN breast) (NN reduction) (NNS controls)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Analysis))
      (PP (IN of)
        (NP
          (NP (JJ cultured) (NN blood) (NNS lymphocytes))
          (PP (IN from)
            (NP (DT the) (NN patient))))))
    (VP (VBD established)
      (SBAR (IN that)
        (S
          (NP (PRP they))
          (VP (VBD had)
            (NP
              (NP
                (NP (JJ normal) (NN NER) (NN capacity))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 99.6) (NN %))
                    (PP (IN of)
                      (NP
                        (NP (DT the) (NN average))
                        (PP (IN of)
                          (NP (PRP$ our) (CD 33) (JJ normal) (NNS samples))))))
                  (-RRB- -RRB-)))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (CD 4))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP (DT This))
      (VP (VBZ is)
        (ADVP (RB well)
          (PP (IN above)
            (NP (DT the) (NN cut-off))))
        (VP (VBN established)
          (PP (IN in)
            (NP (PRP$ our) (JJ sporadic) (NN breast) (NN cancer) (NN population))))))
    (, ,)
    (VP (VBZ <)
      (NP (CD 70) (NN %)))
    (NP
      (NP (JJ average) (JJ normal) (NN activity))
      (, ,)
      (SBAR
        (WHNP (WDT which))
        (S
          (SBAR
            (WHADVP (WRB when))
            (S
              (VP (VBN applied)
                (PP (TO to)
                  (NP (PRP$ our) (NNS cases)
                    (CC and)
                    (NNS controls))))))
          (VP (VBD yielded)
            (NP
              (NP (DT a) (JJ significant) (NNS odds) (NN ratio))
              (PP (IN of)
                (NP (CD 37.4) (VBG -LSB-) (CD 31) (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT A) (NN trend))
        (PP (IN towards)
          (NP (NN age) (NN dependence))))
      (VP (VBD had)
        (VP (VBN been)
          (VP (VBN noted)
            (PP (IN in)
              (NP
                (NP (DT the) (NN analysis))
                (PP (IN of)
                  (NP
                    (NP (DT the) (NNP UDS) (NN data))
                    (PP (IN of)
                      (NP
                        (NP (DT the) (JJ normal) (NNS controls))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP P)
                            (QP (CD =) (CD 0.059)))
                          (-RRB- -RRB-))))))))
            (S
              (VP (VBG -LSB-)
                (NP (CD 30) (NNS -RSB-))))))))
    (: ;)
    (S
      (S
        (NP
          (NP (NN addition))
          (PP (IN of)
            (NP (DT the) (JJ patient) (NN sample))))
        (VP (VBZ supports)
          (NP (DT this) (NN trend))))
      (, ,)
      (CC but)
      (S
        (NP (PRP it))
        (ADVP (RB still))
        (VP (VBZ fails)
          (S
            (VP (TO to)
              (VP (VB reach)
                (NP (NN significance))
                (PRN (-LRB- -LRB-)
                  (NP (NNP P)
                    (QP (CD =) (CD 0.056)))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP functional) (NNP NER))
    (ADVP (RB assay))
    (VP (VBD was)
      (ADVP (RB then))
      (VP (VBN applied)
        (PP (TO to)
          (NP
            (NP (DT the) (JJ contemporaneous) (JJ disease-free) (NN breast) (NN reduction) (NN control) (NN sample))
            (, ,)
            (NP
              (NP (CD one) (NN sample))
              (NP (DT each)))))
        (PP
          (PP (IN from)
            (NP
              (NP (DT the)
                (ADJP (JJ ipsilateral)
                  (CC and)
                  (JJ contralateral))
                (NNS breasts))
              (PP (IN of)
                (NP (DT the) (NN patient)))))
          (, ,)
          (CC and)
          (PP (TO to)
            (NP
              (NP (DT a) (NN sample))
              (PP (IN from)
                (NP
                  (NP (DT the) (JJ contralateral) (NN breast))
                  (PP (IN of)
                    (NP (DT an)
                      (ADJP (RB apparently) (JJ sporadic))
                      (NN breast) (NN cancer) (NN patient))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NNP NER))
      (PP (IN of)
        (NP (DT the) (NNP BRE) (JJ non-diseased) (NN control))))
    (VP (VBD was)
      (NP
        (NP
          (QP (CD 1.82) (NNS times)))
        (NP (DT the) (NN average))
        (PP (IN of)
          (NP
            (NP (PRP$ our) (JJ normal) (NNS data))
            (VP (VBN set)
              (PP
                (PP (IN for)
                  (NP (DT this) (NN tissue)))
                (CC and)
                (PP (IN within)
                  (NP
                    (NP (DT the) (NN range))
                    (PP (IN of)
                      (NP (JJ normal)))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NNP NER) (NN capacity))
      (PP (IN of)
        (NP (DT the) (JJ ipsilateral) (NN breast) (NN epithelial) (NN sample))))
    (VP (VBD was)
      (NP
        (NP
          (QP (CD 1.05) (NNS times)))
        (NP (DT the) (NN average))
        (PP (IN of)
          (NP
            (NP (PRP$ our) (NN population))
            (PP (IN of)
              (NP (NNP BRE) (NNS controls)))
            (, ,)
            (VP
              (ADVP (RB clearly))
              (VBG exhibiting)
              (NP
                (NP (DT no) (JJ overt) (NN DNA) (NN repair) (NN deficiency))
                (PRN (-LRB- -LRB-)
                  (NP (NN Figure) (CD 5))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ contralateral) (NN sample))
    (VP (VBD was)
      (ADJP (RB very) (JJ similar))
      (, ,)
      (PP (IN with)
        (NP
          (NP (DT an) (NNP NER) (NN capacity))
          (PP (IN of)
            (NP
              (QP (CD 1.17) (NNS times))
              (NNP BRE) (NNS normal))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP
          (NP (DT the) (NNP NER) (NNS values))
          (PP (IN of)
            (NP
              (NP (DT these) (CD two) (NNS samples))
              (PP (IN from)
                (NP (DT the) (JJ same) (NN patient))))))
        (VP (VBP are)
          (ADJP (JJ similar)))))
    (, ,)
    (NP (PRP they))
    (VP (VBP are) (RB not)
      (ADJP (RB close) (JJ enough)
        (S
          (VP (TO to)
            (VP (VB distinguish)
              (NP (PRP themselves))
              (PP (IN as)
                (S
                  (VP (VBG coming)
                    (PP (IN from)
                      (NP
                        (NP (DT the) (JJ same) (NN individual))
                        (PRN (-LRB- -LRB-)
                          (NP (NNP P) (NNP =) (NNP 0.16))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NNP NER) (NN capacity))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ contralateral) (NN sample))
          (PP (IN from)
            (NP (DT the) (JJ sporadic) (NN breast) (NN cancer) (NN patient))))))
    (VP (VBD was)
      (NP (CD 1.62) (NNS times))
      (NP
        (NP
          (NP
            (NP (DT the) (NN average))
            (PP (IN of)
              (NP (DT the) (NNP BRE) (NNS controls))))
          (, ,)
          (ADVP (RB also)))
        (PP (IN in)
          (NP (DT the) (JJ normal) (NN range)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (PRP$ Our) (JJR earlier) (NN analysis))
      (PP (IN of)
        (NP
          (NP (NNP NER))
          (PP (IN in)
            (NP (PRP$ our) (JJ normal) (NN population))))))
    (VP (VBD revealed)
      (NP
        (NP (DT no) (NNS effects))
        (PP (IN of)
          (NP
            (NP (NN age)
              (CC or)
              (NN cell) (NN proliferation))
            (PRN (-LRB- -LRB-)
              (SBAR (IN as)
                (S
                  (VP (VBD represented)
                    (PP (IN by)
                      (NP (DT the) (NNP SPI))))))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT All))
      (PP (IN of)
        (NP (DT these) (JJ additional) (JJ patient) (NNS samples))))
    (VP (VBP are)
      (ADJP (JJ consistent)
        (PP (IN with)
          (NP (DT those) (NNS results)))))
    (. .)))

(ROOT
  (S
    (NP (NNP Discussion))
    (ADVP (IN At) (JJS least))
    (NP
      (NP (CD two) (NNS types))
      (PP (IN of)
        (NP (NN breast) (NNS tumors))))
    (VP (VBP are) (RB not)
      (ADVP (RB accurately))
      (VP (VBN detected)
        (PP (IN by)
          (NP
            (NP (JJ traditional) (NN screening) (NN mammography))
            (: :)
            (NP
              (NP
                (NP (`` ``) (JJ interval) ('' '') (NNS tumors))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (VBP arise)
                      (ADVP (RB quickly))
                      (PP (IN between)
                        (NP (NNS screenings)))))))
              (, ,)
              (CC and)
              (NP
                (NP (NNS tumors))
                (SBAR
                  (WHNP (WP$ whose) (NNS density))
                  (S
                    (VP (VBZ is) (RB not)
                      (ADJP (JJ sufficient)
                        (S
                          (VP (TO to)
                            (VP (VB distinguish)
                              (NP (PRP them))
                              (PP (IN from)
                                (NP (DT the) (VBG surrounding) (JJ normal) (NN tissue))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ latter) (NN situation))
    (VP (VBZ is)
      (ADJP (RBR more) (JJ likely)
        (S
          (VP (TO to)
            (VP (VB occur)
              (PP (IN in)
                (NP (NNS women)))
              (PP (IN with)
                (NP
                  (NP (JJ dense) (JJ normal) (NN breast) (NN tissue))
                  (, ,)
                  (SBAR
                    (WHNP (WDT which))
                    (S (, ,)
                      (PP (IN in)
                        (NP (NN turn)))
                      (, ,)
                      (VP (VBZ is)
                        (ADJP (RBR more) (JJ typical)
                          (PP (IN of)
                            (NP (JJR younger) (NNS women))))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Thus))
    (, ,)
    (NP (JJ mammographically) (NN undetectable) (NNS tumors))
    (VP (MD may)
      (VP (VB have)
        (NP
          (NP (DT a) (NN number))
          (PP (IN of)
            (NP (NNS characteristics)))
          (, ,)
          (PP (JJ such) (IN as)
            (NP
              (NP
                (NP (JJ fast) (NN growth))
                (, ,)
                (NP (JJ low) (NN density))
                (, ,)
                (NP
                  (NP (JJ early) (NN onset) (NN and/or) (NN occurrence))
                  (PP (IN in)
                    (NP (JJ dense) (NNS breasts)))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (MD might)
                        (VP (VB distinguish)
                          (NP (PRP them))
                          (PP (IN from)
                            (NP
                              (NP
                                (ADJP (RB mammographically) (JJ detectable))
                                (NNS tumors))
                              (PP (IN in)
                                (NP
                                  (NP (NNS terms))
                                  (PP (IN of)
                                    (NP (JJ molecular) (NN etiology)))))))))))))
              (CC and)
              (NP
                (NP (JJ clinical) (NNS parameters))
                (PP (IN of)
                  (NP (NN prognosis)
                    (CC and)
                    (NN response)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT The) (JJ present) (NN patient))
      (VP
        (VP (VBD had)
          (NP (DT an) (JJ early) (NN onset) (NN breast) (NN tumor)))
        (, ,)
        (CC but)
        (VP (VBD had)
          (NP
            (NP (DT both) (NN hereditary))
            (ADJP (RB susceptibility) (JJ due)))
          (PP (TO to)
            (NP
              (NP (PRP$ her) (JJ BRCA1) (NN mutation))
              (CC and)
              (NP (JJ dense) (NNS breasts)))))))
    (, ,) (IN so)
    (S
      (NP (PRP$ her) (NN presentation))
      (VP (VBZ is) (RB not)
        (ADJP (JJ unusual)
          (PP (IN in)
            (NP (DT this) (NN context))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ is)
      (ADJP (JJ possible)
        (SBAR (IN that)
          (S
            (NP
              (NP (NN breast) (NNS tumors))
              (VP (VBN detected)
                (PP (IN by)
                  (NP
                    (NP (JJ complementary) (NN screening) (NNS methods))
                    (PP (IN in)
                      (NP (DT the) (NN future)))))))
            (VP (MD will)
              (VP (VB demonstrate)
                (NP (JJ unique) (JJ clinical)
                  (CC and)
                  (JJ molecular) (NNS features)))))))
      (, ,)
      (SBAR
        (WHADVP (WRB when))
        (S
          (NP (PRP it))
          (VP (VBZ becomes)
            (ADJP (JJ feasible)
              (S
                (VP (TO to)
                  (VP (VB perform)
                    (NP (JJ such) (NN screening))
                    (PP (IN in)
                      (NP (DT the) (JJ general) (NN population)))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Since)
      (S
        (NP (DT the) (NNP BRCA1) (NN gene) (NN product))
        (VP (VBZ is)
          (VP (VBN known)
            (S
              (VP (TO to)
                (VP (VB play)
                  (S
                    (NP
                      (NP (DT a) (NN role))
                      (PP (IN in)
                        (NP (NNP DNA) (JJ double) (NN strand))))
                    (VP (NN break) (VB repair)
                      (NP
                        (QP (CD -LSB-) (CD 8,9))
                        (NNS -RSB-)))))))))))
    (, ,)
    (NP (PRP it))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN suggested)
          (SBAR (IN that)
            (S
              (NP (VBN decreased) (NN repair) (NN capacity))
              (VP (VBZ is)
                (NP
                  (NP (DT the) (NN basis))
                  (PP (IN of)
                    (NP
                      (NP (DT the) (NN breast) (NN cancer) (NN predisposition))
                      (VP (VBN observed)
                        (PP (IN in)
                          (NP (NN mutation) (NNS carriers)))
                        (S
                          (VP (VBG -LSB-)
                            (NP (CD 32-35) (NNS -RSB-))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PDT Such) (DT a) (JJ cellular) (NN phenotype))
    (VP (VBZ has)
      (VP (VBN been)
        (ADJP (JJ difficult)
          (S
            (VP (TO to)
              (VP (VB demonstrate)))))
        (, ,)
        (ADVP (RB however))
        (VP (VBG -LSB-)
          (NP (CD 36-39) (NNS -RSB-)))))
    (. .)))

(ROOT
  (S
    (NP (DT An) (JJ alternate) (NN possibility))
    (VP (VBZ is)
      (SBAR (IN that)
        (S
          (NP (DT the) (NN mutation))
          (VP (VBZ affects)
            (S
              (NP
                (NP (DT the) (NN growth)
                  (CC or)
                  (NN differentiation))
                (PP (IN of)
                  (NP
                    (NP (NN breast) (NN epithelial) (NNS cells))
                    (PP (IN in)
                      (NP (DT a) (NN manner))))))
              (ADJP (JJ consistent)
                (PP (IN with)
                  (NP (NN cancer) (NN susceptibility)))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN suggested)
          (SBAR (IN that)
            (S
              (NP (JJ dense) (NN breast) (NN tissue))
              (VP (VBZ is)
                (ADJP (JJ indicative)
                  (PP (IN of)
                    (NP
                      (NP (JJ generalized) (NN hyperproliferation))
                      (SBAR
                        (WHNP (WDT that))
                        (S
                          (VP (MD might)
                            (VP (VB promote)
                              (NP
                                (NP (NNS oncogenesis))
                                (VP (VBG -LSB-)
                                  (NP (CD 29) (NNS -RSB-)))))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (PRP$ Our) (NNS findings))
      (VP (VBP show)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT all) (CD 8) (NNS samples))
              (, ,)
              (VP (VBN derived)
                (PP (IN from)
                  (NP (PDT both) (DT the)))))
            (VP (VBD involved))))))
    (CC and)
    (S
      (NP
        (NP (DT the) (JJ uninvolved) (NNS breasts))
        (PP (IN of)
          (NP (DT a) (JJ hereditary) (NN breast) (NN cancer) (NN patient))))
      (VP (VBP develop)
        (NP
          (NP (JJ normal) (JJ epithelial) (NN architecture))
          (PP (IN in)
            (NP (NNP vitro))))
        (, ,)
        (S
          (VP (VBG implying)
            (SBAR (IN that)
              (S
                (NP
                  (NP (DT the) (NN epithelial/stromal)
                    (PRN (-LRB- -LRB-)
                      (NP (NN paracrine))
                      (-RRB- -RRB-))
                    (NNS interactions))
                  (ADJP (JJ necessary)
                    (PP (IN for)
                      (NP
                        (NP (DT the) (NN development))
                        (PP (IN of)
                          (NP (DT this) (JJ complex) (NN architecture)))))))
                (VP (VBP are)
                  (ADJP (JJ intact)
                    (CC and)
                    (JJ normal))
                  (PP (IN in)
                    (NP (CD BRCA1) (NNS heterozygotes)))
                  (PP (IN despite)
                    (NP
                      (NP (PRP$ their) (JJR greater) (NN risk))
                      (PP (IN of)
                        (NP (NN breast) (NN cancer))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNP SPI) (NNS results))
    (ADVP (RB also))
    (VP (VBP indicate)
      (SBAR (IN that)
        (S
          (NP (DT this) (JJ non-diseased) (JJ epithelial) (NN tissue))
          (VP
            (VP (VBZ falls)
              (PP (IN into)
                (NP
                  (NP (DT the) (JJ typical) (NN range))
                  (PP (IN of)
                    (NP
                      (ADJP (JJ normal)
                        (PP (IN for)
                          (NP (NNP BRE))))
                      (NN control) (NNS cultures))))))
            (CC and)
            (VP (VBZ is)
              (VP (VBG demonstrating)
                (NP (JJ typical) (NN growth))
                (PP (IN in)
                  (NP (PRP$ our) (NNP HME) (NN tissue) (NN engineering) (NN system)))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP NER) (NN deficiency))
    (VP (VBZ is)
      (ADVP (RBS most) (RB often))
      (VP (VBN associated)
        (PP (IN with)
          (NP
            (NP (NNP XP))
            (, ,)
            (NP (NN sensitivity))))
        (PP (TO to)
          (NP (JJ UV-induced) (NN DNA) (NN damage)
            (CC and)
            (NN skin) (NN cancer) (NNP -LSB-) (NNP 18-21) (NNP -RSB-)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NNP NER) (NN deficiency))
      (PP (IN of)
        (NP (NNP XP) (NNS patients))))
    (VP (VBZ is)
      (VP (VBN manifested)
        (PP (IN in)
          (NP (JJ other) (NNS tissues)))
        (, ,)
        (ADVP (RB however))
        (, ,)
        (SBAR (IN as)
          (S
            (S
              (VP (VBN shown)
                (PP (IN by)
                  (NP
                    (NP (PRP$ their) (JJ high) (JJ spontaneous) (NN frequency))
                    (PP (IN of)
                      (NP (NN mutation)))))
                (PP (IN in)
                  (NP
                    (NP
                      (NP (NN blood) (NNS lymphocytes))
                      (NP
                        (QP (CD -LSB-) (CD 40))
                        (NNS -RSB-)))
                    (CC and)
                    (NP
                      (NP (DT the) (NN occurrence))
                      (PP (IN of)
                        (NP
                          (NP (JJ other) (NNS types))
                          (PP (IN of)
                            (NP (NNS tumors))))))))))
            (VP (VBZ -LSB-)
              (NP (CD 41) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN observation))
      (SBAR (IN that)
        (S
          (NP (JJ sporadic) (NN breast) (NN cancer) (NNS patients))
          (VP (VBP have)
            (NP
              (NP (JJ low) (NNS levels))
              (PP (IN of)
                (NP
                  (NP (NNP NER))
                  (PP (IN in)
                    (NP (JJ peripheral) (NNS lymphocytes))))))))))
    (VP (VBZ suggests)
      (SBAR (IN that)
        (S
          (NP (JJ sporadic) (NN breast) (NN cancer))
          (VP (VBZ is)
            (VP (VBN associated)
              (PP (IN with)
                (NP
                  (NP
                    (ADJP (RB constitutively) (JJ low))
                    (NNS levels))
                  (PP (IN of)
                    (NP (NNP NER) (NNP -LSB-) (NNP 14-16) (NNP -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (PRP$ Our) (NNS results))
      (PP (IN from)
        (NP (DT a) (JJ single) (NN patient))))
    (VP (VBP demonstrate) (, ,)
      (ADVP (RB however))
      (, ,)
      (SBAR (IN that)
        (S
          (SBAR (IN while)
            (S
              (NP
                (NP (NN overexpression))
                (PP (IN of)
                  (NP (NNP BRCA1))))
              (VP (MD may)
                (VP (VB enhance)
                  (NP (NNP NER) (NNP -LSB-) (CD 22) (NNP -RSB-))))))
          (, ,)
          (NP
            (NP (NN haploinsufficiency))
            (PP (IN for)
              (NP (DT this) (NN gene))))
          (VP (VBZ does) (RB not)
            (ADVP (RB necessarily))
            (VP (VB result)
              (PP (IN in)
                (NP (JJ detectable) (NNP NER) (NN deficiency))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Since)
      (S
        (NP (PRP it))
        (VP (VBZ is)
          (ADJP (JJ clear))
          (SBAR (IN that)
            (S
              (NP (JJ genomic) (NN instability))
              (VP (VBZ is)
                (NP
                  (NP (DT a) (JJ necessary) (NN prerequisite))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN completion))
                      (PP (IN of)
                        (NP
                          (NP
                            (NP (DT the) (JJ complex) (NN multi-step))
                            (ADJP (JJ carcinogenic) (JJ pathway)))
                          (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-))))
                      (VP (VBN involved)
                        (PP (IN in)
                          (NP (NN breast) (NN cancer)))))))))))))
    (, ,)
    (NP
      (NP (DT a) (JJ fundamental) (NN difference))
      (PP (IN in)
        (NP
          (NP (DT the) (NNS mechanisms))
          (PP (IN of)
            (NP
              (NP (JJ genomic) (NN instability))
              (VP (VBG arising)
                (PP (IN in)
                  (NP
                    (ADJP (JJ hereditary)
                      (CC and)
                      (JJ sporadic))
                    (NN breast) (NNS tumors)))))))))
    (VP (MD would)
      (VP (VB be)
        (ADJP (JJ likely)
          (S
            (VP (TO to)
              (VP (VB translate)
                (PP (IN into)
                  (NP
                    (NP
                      (ADJP (RB fundamentally) (JJ different))
                      (NNS patterns))
                    (PP (IN of)
                      (NP
                        (NP (JJ molecular) (NNS pathogenesis))
                        (SBAR
                          (WHNP (WDT that))
                          (S
                            (VP (MD could)
                              (VP (VB impact)
                                (PP (IN on)
                                  (NP (JJ clinical) (NN management)))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ relative) (NNP NER) (NNS capacities))
      (PP (IN of)
        (NP (NN tumor)
          (CC and)
          (JJ normal) (NN tissue))))
    (VP (MD may)
      (VP (VB have)
        (NP (JJ important) (JJ practical) (NNS implications))))
    (. .)))

(ROOT
  (S
    (SBAR (IN If)
      (S
        (NP
          (NP (NN breast) (NNS tumors))
          (PP (IN from)
            (NP (JJ hereditary) (NNS patients))))
        (VP (VB exhibit)
          (S
            (NP (NNP NER) (NN deficiency))
            (ADJP (JJ similar)
              (PP (TO to)
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (VBD observed)
                      (PP (IN in)
                        (NP (JJ sporadic) (NNS patients)))
                      (, ,)
                      (SBAR (IN while)
                        (S
                          (NP (PRP$ their) (JJ normal) (NNS tissues))
                          (VP (VB exhibit)
                            (NP
                              (NP (JJ normal) (NNS levels))
                              (PP (IN of)
                                (NP
                                  (NP (DT this) (NN type))
                                  (PP (IN of)
                                    (NP (NN DNA) (NN repair))))))))))))))))))
    (, ,)
    (NP (RB then) (DT the) (NNS tumors))
    (VP (MD would)
      (VP (VB be)
        (ADJP (JJ hypersensitive)
          (PP (TO to)
            (NP
              (NP (DT a) (NN range))
              (PP (IN of)
                (NP (JJ chemotherapeutic) (NNS drugs)))
              (, ,)
              (PP (VBG including)
                (NP
                  (NP
                    (NP (JJ alkylating) (NNS agents))
                    (PRN (-LRB- -LRB-)
                      (NP (NN cyclosphosphamide))
                      (-RRB- -RRB-)))
                  (, ,)
                  (NP
                    (NP (JJ cross-linking) (NNS agents))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP cis-platinum))
                      (-RRB- -RRB-)))
                  (CC and)
                  (NP
                    (NP (JJ bulky) (NNP DNA) (NN adducting) (NNS agents))
                    (PRN (-LRB- -LRB-)
                      (NP (NN melphalan))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Individualization))
      (PP (IN of)
        (NP
          (NP (NN chemotherapy))
          (VP (VBN based)
            (PP (IN on)
              (NP
                (NP (DT some) (NN aspect))
                (PP (IN of)
                  (NP (NNP NER) (NN expression)))))))))
    (VP (VBZ is)
      (VP (VBG being)
        (VP (VBN pursued)
          (PP (IN in)
            (NP
              (NP
                (NP (NN colon) (NNS -LSB-))
                (NP (CD 42) (NNS -RSB-)))
              (, ,)
              (NP
                (NP (NN testicular) (NNS -LSB-))
                (NP (CD 43,44) (NNS -RSB-)))
              (CC and)
              (NP
                (NP (NN ovarian) (NN cancer))
                (NP
                  (QP (CD -LSB-) (CD 45))
                  (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Conclusion) (DT This) (NN patient))
      (CC and)
      (NP (PRP$ her) (NN tumor)))
    (VP (VBP represent)
      (NP
        (NP (DT the) (NN vanguard))
        (PP (IN of)
          (NP
            (NP (DT a) (JJ new) (NN population))
            (PP (IN of)
              (NP
                (NP (JJ early) (NN stage) (NN breast) (NN cancer) (NNS patients))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (MD will)
                      (VP
                        (VP (VB be)
                          (VP
                            (ADVP (RB increasingly))
                            (VBN diagnosed)
                            (SBAR (IN as)
                              (S
                                (NP
                                  (NP (JJ new) (NN screening) (NNS technologies))
                                  (ADJP (JJ complementary) (TO to) (JJ mammography)))
                                (VP (VBP are)
                                  (VP (VBN validated)))))))
                        (CC and)
                        (VP (VB become)
                          (NP (NN practicable)))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (PRP We))
      (VP (VBP have)
        (VP (VBN shown)
          (SBAR (IN that)
            (S
              (NP (JJ low) (NN power) (NNS MRI))
              (VP (MD can)
                (VP (VB detect)
                  (NP (DT a) (NN stage) (NN I) (NN tumor))
                  (PP (IN in)
                    (NP (JJ dense) (NN breast) (NN tissue))))))))))
    (: ;)
    (S
      (NP (DT the) (JJ same) (NN technology))
      (VP (MD can)
        (ADVP (RB also))
        (VP (VB impact)
          (PP (IN upon)
            (NP (JJ interval) (NNS tumors)))
          (PP (IN by)
            (S
              (VP
                (VP (VBG staggering)
                  (NP (DT the) (NN procedure))
                  (PP (IN with)
                    (NP (NN mammography))))
                (CONJP (RB rather) (IN than))
                (VP (VBG applying)
                  (NP (PRP them))
                  (ADVP (RB coincidently)))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN Although)
      (S
        (NP (PRP we))
        (VP (VBD did) (RB not)
          (VP (VB observe)
            (NP (JJ obvious) (NNS differences))
            (PP (IN in)
              (NP
                (NP (DT the) (NN growth) (NN rate)
                  (CC or)
                  (NN differentiation) (NN potential))
                (PP (IN of)
                  (NP (DT the) (JJ dense) (NN breast) (NN tissue)))))
            (PP (IN from)
              (NP (DT this) (NN patient)))))))
    (, ,)
    (NP (PRP we))
    (VP (MD can) (RB not)
      (VP (VB rule)
        (PRT (RP out))
        (NP (DT the) (NN possibility))
        (SBAR (IN that)
          (S
            (NP
              (NP (DT some))
              (CC or)
              (NP
                (NP (DT all))
                (PP (IN of)
                  (NP
                    (NP (DT the) (NNS tumors))
                    (ADJP (JJ detectable)
                      (PP (RB only) (IN by)
                        (NP (JJ complementary) (NN screening) (NNS procedures))))))))
            (VP (MD will)
              (VP (VB differ)
                (PP (IN from)
                  (NP
                    (NP (DT the) (JJ present) (JJ clinical) (NN experience))
                    (PP (IN in)
                      (NP (JJ important) (NNS ways)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (PRP$ Our) (JJ live-cell) (NN analysis))
      (VP (VBZ takes)
        (NP (DT a) (NN step))
        (PP (IN toward)
          (S
            (VP (VBG defining)
              (NP
                (NP (JJ cellular) (NNS characteristics))
                (SBAR
                  (WHNP (WDT that))
                  (S
                    (VP (MD may)
                      (VP (VB be)
                        (ADJP (JJ useful)
                          (PP (IN for)
                            (NP (NN cancer) (NN risk) (NN assessment))))))))))))))
    (, ,)
    (CC but)
    (S
      (NP (PRP we))
      (VP (VBP are)
        (ADVP (RB only))
        (VP (VBG beginning)
          (S
            (VP (TO to)
              (VP (VB investigate)
                (NP
                  (NP (DT the) (NNS possibilities))
                  (PP (IN of)
                    (NP (DT the) (NN system))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP It))
    (VP (MD may)
      (VP (VB be)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ different) (NN growth) (NNS conditions))
              (, ,)
              (CC or)
              (NP
                (NP (NN induction))
                (PP (IN with)
                  (NP
                    (ADJP (JJ genotoxic)
                      (CC or)
                      (JJ estrogenic))
                    (NNS agents))))
              (, ,))
            (VP (MD will)
              (VP (VB allow)
                (PP (IN for)
                  (NP
                    (NP (DT the) (JJR greater) (NN differentiation))
                    (PP (IN of)
                      (NP (NN breast) (NN tissue)
                        (CC and)
                        (NN tumor) (NNS behaviours)))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN technique))
    (ADVP (RB also))
    (VP (VBZ allows)
      (PP (IN for)
        (NP
          (NP (DT the) (NN application))
          (PP (IN of)
            (NP (JJ functional) (NNS assays)))))
      (PP (TO to)
        (NP (JJ patient) (NNS samples)))
      (, ,)
      (SBAR (IN as)
        (S
          (VP (VBN exemplified)
            (PP (IN in)
              (NP (DT this) (NN report)))
            (PP (IN by)
              (NP (DT the) (NNP UDS) (NN assay)))
            (PP (IN for)
              (NP (NNP NER) (NN capacity)))))))
    (. .)))

(ROOT
  (S
    (NP (DT Those) (NNP UDS) (NNS results))
    (, ,)
    (SBAR (IN although)
      (FRAG
        (PP (IN from)
          (NP (DT a) (JJ single) (NN patient)))))
    (, ,)
    (VP (VBP demonstrate)
      (ADVP (RB definitively))
      (SBAR (IN that)
        (S
          (NP (DT the) (JJ constitutively) (JJ low) (NNP NER) (NNS capacities))
          (VP (VBD reported)
            (SBAR (IN in)
              (S
                (NP (JJ several) (JJ sporadic) (NN breast) (NNS populations))
                (VP (VBP do) (RB not)
                  (VP (VB arise)
                    (PP (IN as)
                      (NP
                        (NP (DT a) (JJ pleiomorphic) (NN effect))
                        (PP (IN of)
                          (NP (NNP BRCA1)))))
                    (ADVP (RB haploinsufficency))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Thus))
    (, ,)
    (NP
      (NP
        (NP (DT the) (NN basis))
        (PP (IN of)
          (NP (JJ genetic) (NN instability))))
      (, ,)
      (NP
        (NP (DT a) (JJ fundamental) (NN element))
        (PP (IN in)
          (NP (NN breast) (NNS carcinogenesis))))
      (, ,))
    (VP (MD may)
      (VP (VB differ)
        (PP (IN between)
          (NP
            (ADJP (JJ sporadic)
              (CC and)
              (JJ hereditary))
            (NN breast) (NNS tumors)))))
    (. .)))

(ROOT
  (S
    (NP (DT This))
    (VP (VBZ results)
      (PP (IN in)
        (NP
          (NP (JJ different) (NNS susceptibilities))
          (PP (TO to)
            (S
              (VP (VBG inducing)
                (NP
                  (NP (NNS agents))
                  (, ,)
                  (NP
                    (NP (NNS mutations))
                    (PP (IN in)
                      (NP
                        (NP
                          (NP (JJ different) (NNS sets))
                          (PP (IN of)
                            (NP
                              (NP (NNS oncogenes))
                              (CC and)
                              (NP (NN tumor) (NN suppressor) (NNS genes)))))
                        (, ,)
                        (CC and)
                        (, ,)
                        (ADVP (RB ultimately))
                        (, ,)
                        (NP
                          (NP (NNS tumors))
                          (PP (IN of)
                            (NP (JJ different) (JJ molecular) (NN etiology))))))
                    (SBAR
                      (WHNP (WDT that))
                      (S
                        (VP (VBP express)
                          (NP (JJ different)
                            (ADJP (RB clinically) (JJ relevant))
                            (NNS phenotypes)))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Methods))
    (NP (DT The) (NN patient))
    (VP (VBD was)
      (NP
        (NP (DT a) (JJ 35.7) (NN year) (JJ old) (NN woman))
        (PP (IN with)
          (NP
            (NP (JJ strong) (NN family) (NN history))
            (PP (IN of)
              (NP
                (NP (NN breast) (NN cancer))
                (VP (VBN recruited)
                  (PP (IN into)
                    (NP
                      (NP (DT a) (JJ clinical) (NN trial))
                      (PP (IN of)
                        (NP (NNP MRI)))))
                  (S
                    (VP (VBG screening)
                      (PP (IN for)
                        (NP (JJ young) (NN woman)))
                      (PP (IN at)
                        (NP
                          (NP (JJ high) (NN risk))
                          (PP (IN for)
                            (NP (NN breast) (NN cancer)))))
                      (PP (IN with)
                        (NP
                          (NP (JJ dense) (NN breast) (NN tissue))
                          (VP (VBG -LSB-)
                            (NP
                              (QP (CD 3) (CD -RSB-)))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Gadolinium) (NN enhancement) (NNS images))
    (VP (VBD revealed)
      (NP
        (NP (DT a) (JJ small) (CD 1) (NN cm) (NN lesion))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ upper-outer) (NN quadrant))
            (PP (IN of)
              (NP
                (NP (DT the) (JJ left) (NN breast))
                (, ,)
                (VP (VBN identified)
                  (ADVP (RB pathologically)
                    (PP (IN as)
                      (NP (DT an) (JJ infiltrating) (JJ ductal) (NN carcinoma)))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN patient))
    (VP
      (VP (VBD underwent)
        (NP
          (NP (DT a) (VBN modified) (JJ radical) (NN mastectomy))
          (PP (IN of)
            (NP (DT the) (JJ left) (NN breast)))))
      (CC and)
      (VP (VBD chose)
        (S
          (VP (TO to)
            (VP
              (ADVP (RB also))
              (VB undergo)
              (NP (DT a) (JJ contralateral) (JJ prophylactic) (JJ total) (NN mastectomy)))))))
    (. .)))

(ROOT
  (S
    (NP (NN Blood)
      (CC and)
      (NN tissue))
    (VP (VBD were)
      (VP (VBN obtained)
        (PP (IN for)
          (NP (NN analysis)))
        (PP (IN with)
          (NP (NN consent)))
        (PP (IN under)
          (NP
            (NP (NNP Magee-Womens) (NNP Hospital)
              (PRN (-LRB- -LRB-)
                (PP (IN of)
                  (NP
                    (NP (DT the) (NNP University))
                    (PP (IN of)
                      (NP (NNP Pittsburgh) (NNP Medical) (NNP Center)))))
                (-RRB- -RRB-))
              (NNP IRB))
            (NP (# #) (CD MWH-94-108))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Data))
      (PP (IN from)
        (NP (DT this) (JJ hereditary) (NN breast) (NN cancer) (NN patient))))
    (VP (VBD were)
      (PP (VBN compared)
        (PP (TO to)
          (NP
            (NP
              (NP (DT that))
              (PP (IN from)
                (NP (CD two) (JJ additional) (NNS patients))))
            (CONJP (RB as) (RB well) (IN as))
            (NP (RB previously) (VBN published) (NNS controls))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ first) (JJ new) (NN control) (NN patient))
    (VP (VBD was)
      (NP
        (NP (DT a)
          (ADJP (CD 20) (NN year) (JJ old))
          (NNS women))
        (VP (VBG undergoing)
          (NP (NN breast) (NN reduction))
          (ADVP (RB mammoplasty)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ second) (JJ contemporaneous) (NN control) (NN patient))
    (VP (VBD was)
      (NP
        (NP (DT a)
          (ADJP (CD 36) (NN year) (JJ old))
          (NN woman))
        (VP (VBG undergoing)
          (NP
            (NP (JJ cosmetic) (NN surgery))
            (PP (IN on)
              (NP (PRP$ her) (JJ contralateral) (NN breast))))
          (PP
            (NP (CD two) (NNS years))
            (IN after)
            (NP
              (ADJP (JJ successful) (RB lumpectomy)
                (S
                  (VP (TO to)
                    (VP (VB remove)
                      (NP (DT an)
                        (ADJP (RB apparently) (JJ sporadic))
                        (NN stage) (NN IIA) (NN breast))))))
              (NN tumor))))
        (PRN (-LRB- -LRB-)
          (S
            (NP
              (NP (CD 2.5) (NN cm))
              (, ,)
              (ADJP (JJ negative)
                (PP (IN for)
                  (NP (NN estrogen)
                    (CC and)
                    (NN progesterone) (NNS receptors))))
              (, ,)
              (NP (CD 13) (NN lymph) (NNS nodes)))
            (ADJP (JJ negative)))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (PRP She))
    (VP (VBD had)
      (VP (VBN undergone)
        (NP (JJ standard) (NN radiotherapy)
          (CC and)
          (NN chemotherapy))
        (PP (IN with)
          (NP (NN adriamycin)
            (CC and)
            (NN cyclophosphamide)))))
    (. .)))

(ROOT
  (S
    (NP (JJ Histopathological) (NN analysis))
    (VP (VBD confirmed)
      (SBAR (IN that)
        (S
          (NP
            (NP (DT the) (NN breast) (NN tissue))
            (PP (IN from)
              (NP
                (NP (DT both))
                (PP (IN of)
                  (NP (DT these) (NN control) (NNS patients))))))
          (VP (VBD was)
            (ADJP (JJ free))
            (PP
              (PP (IN of)
                (NP (NN cancer)))
              (CC and)
              (PP (IN within)
                (NP
                  (NP (DT the)
                    (ADJP (JJ acceptable) (JJ histological))
                    (NN range))
                  (PP (IN of)
                    (NP (JJ normal))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Fresh) (NNS tissues))
      (PP (IN from)
        (NP (DT the) (NN patient))))
    (VP (VBD were)
      (VP (VBN obtained)
        (PP (IN within)
          (NP
            (NP (CD 5) (NNS hours))
            (PP (IN of)
              (NP (NN surgery)))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP (JJ pathological) (NN evaluation)))
    (, ,)
    (NP
      (NP (JJ excess) (NN tissue))
      (VP (RB not) (VBN needed)
        (PP (IN for)
          (NP (NN diagnosis)))))
    (VP (VBD was)
      (VP (VBN placed)
        (PP (IN into)
          (NP (NNP DMEM)))
        (S
          (VP (VBG containing)
            (NP
              (NP
                (ADJP (CD 10) (NN %))
                (JJ fetal) (JJ calf) (NN serum))
              (CC and)
              (NP
                (NP (JJ 3x) (JJ antibiotic) (NN antimycotic))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Sigma))
                  (, ,)
                  (NP (NNP St.) (NNP Louis))
                  (, ,)
                  (NP (NNP MO))
                  (-RRB- -RRB-))))
            (PP (IN at)
              (NP (CD 4) (NN °) (NNP C)))))))
    (. .)))

(ROOT
  (S
    (NP (DT This) (NN tissue))
    (VP (VBD was)
      (ADVP (RB then))
      (VP (VBN processed)
        (SBAR (IN as)
          (S
            (S
              (VP (VBN described)
                (PP (IN in)
                  (NP
                    (NP (NNP Latimer)
                      (CC et)
                      (NNP al.) (NNP -LSB-) (CD 30))
                    (VP (VBN -RSB-)
                      (CC and)
                      (VBN placed)
                      (PP (IN into)
                        (NP
                          (NP (NN culture))
                          (PP (IN on)
                            (NP
                              (NP (DT a) (JJ diluted) (NN form))
                              (PP (IN of)
                                (NP
                                  (NP
                                    (NP (NN matrigel))
                                    (PRN (-LRB- -LRB-)
                                      (NP
                                        (NP (CD 1:1))
                                        (PP (IN with)
                                          (NP (NNP DMEM))))
                                      (-RRB- -RRB-)))
                                  (PP (IN in)
                                    (NP (DT the) (NN novel) (NN MWRIα) (NN medium))))))))))))))
            (VP (VBZ -LSB-)
              (NP (CD 7) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD Eight) (NNS samples))
      (PP (IN of)
        (NP
          (NP (DT the) (JJ principal) (NN patient) (POS 's))
          (NN tissue))))
    (VP (VBD were)
      (VP (VBN obtained)
        (PP (IN for)
          (NP (NN culture)))
        (PP (IN after)
          (NP (JJ bilateral) (JJ mastectomy) (NN surgery)))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD were) (RB not)
      (ADJP (JJ able)
        (S
          (VP (TO to)
            (VP (VB obtain)
              (NP
                (NP (DT a) (NN sample))
                (PP (IN of)
                  (NP (PRP$ her) (NN tumor))))
              (, ,)
              (SBAR (IN because)
                (S
                  (NP (PRP it))
                  (VP (VBD was)
                    (VP (VBN utilized)
                      (ADVP (RB entirely))
                      (PP (IN for)
                        (NP (JJ clinical) (NN diagnosis))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (VP (VBD were)
      (ADJP (JJ able)
        (S
          (VP (TO to)
            (VP (VB obtain)
              (NP
                (NP (CD 4) (NNS pieces))
                (PP (IN of)
                  (NP
                    (ADJP (RB histologically) (JJ normal))
                    (JJ non-tumor) (JJ adjacent) (NN tissue))))
              (PP (IN at)
                (S
                  (VP (VBG increasing)
                    (NP (CD 1) (NN cm) (NNS intervals))
                    (PP (IN from)
                      (NP
                        (NP (DT the) (NN tumor) (NN margin))
                        (PP (IN from)
                          (NP (PRP$ her) (JJ left)
                            (PRN (-LRB- -LRB-)
                              (NP (NN ipsilateral))
                              (-RRB- -RRB-))
                            (NN breast)))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (PRP we))
    (VP (VBD obtained)
      (NP
        (NP (CD 4) (JJ similar) (NNS pieces))
        (PP (IN of)
          (NP (JJ fresh) (NN tissue))))
      (PP (IN from)
        (NP (PRP$ her) (JJ contralateral) (NN breast))))
    (. .)))

(ROOT
  (S
    (NP (DT All))
    (VP (VBD were)
      (VP (VBN placed)
        (PP (IN into)
          (NP (JJ primary) (JJ explant) (-LRB- -LRB-) (NNP HME) (-RRB- -RRB-) (NN culture)))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP
        (NP
          (NP (NN analysis))
          (PP (IN of)
            (NP (NN cell) (NN growth))))
        (CC and)
        (NP
          (ADJP (IN in) (NN vitro))
          (NN differentiation))))
    (, ,)
    (NP (NNS explants))
    (VP (VBD were)
      (VP
        (VP (VBN cultured))
        (CC and)
        (VP (VBN imaged)
          (NP
            (NP (DT every) (JJ second) (NN day))
            (VP (VBG using)
              (NP
                (NP
                  (NP (DT a) (JJ digital) (NNP Hamamatsu) (NNP Orca) (NN camera))
                  (PP (IN for)
                    (NP (CD 30))))
                (: --)
                (NP (CD 60) (NNS days))))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Images))
    (VP (VBD were)
      (VP (VBN analyzed)
        (PP (IN on)
          (NP (DT a) (NNP Macintosh) (NNP G4) (NN computer)))
        (S
          (VP (VBG using)
            (NP
              (NP (NNP QED) (NN imaging) (NN software))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NNP Media) (NNP Cybernetics))
                  (, ,)
                  (NP (NNP Inc.))
                  (, ,)
                  (NP (NNP Silver) (NNP Spring))
                  (, ,)
                  (NP (NNP MD)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Breast) (NN reduction) (NN mammoplasty) (NNS tissues))
    (VP (VBD were)
      (VP (VBN obtained)
        (PP (IN from)
          (NP
            (NP (NNS patients) (NNS ages))
            (NP (CD 20) (: --) (CD 70))))
        (PP (IN at)
          (NP
            (NP (NNP Magee-Womens) (NNP Hospital))
            (PP (IN under)
              (NP (DT the) (JJ above) (NN IRB)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (JJ neighboring) (NN piece))
      (PP (IN of)
        (NP (JJ mammoplasty) (NN tissue)))
      (PRN (-LRB- -LRB-)
        (PP (IN from)
          (NP (DT the) (JJ same) (CD 0.25) (JJ cm2) (NN sample)))
        (-RRB- -RRB-))
      (PP (TO to)
        (NP
          (NP (DT that))
          (VP (VBN placed)
            (PP (IN into)
              (NP (JJ primary) (NN culture)))))))
    (VP (VBD was)
      (VP (VBN fixed)
        (CC and)
        (VBN processed)
        (PP (IN in)
          (NP (NN paraffin)))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS sections))
    (VP (VBD were)
      (VP (VBN examined)
        (PP (IN by)
          (NP (DT a) (NN pathologist)))
        (S
          (VP (TO to)
            (VP (VB verify)
              (NP
                (NP (DT the) (JJ histological) (NNS features))
                (CC and)
                (NP
                  (NP (NN normality))
                  (PP (IN of)
                    (NP (DT the) (NN tissue))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Breast) (NN tissue))
    (VP (VBD was)
      (VP (VBN processed)
        (SBAR (IN as)
          (S
            (ADVP (RB previously))
            (VP (VBD described)
              (NP
                (QP (CD -LSB-) (CD 30))
                (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Tissue))
    (VP (VBD was)
      (VP
        (VP (VBN rinsed)
          (PP
            (NP (CD three) (NNS times))
            (IN in)
            (NP (NNP PBS)))
          (S
            (VP (VBG containing)
              (NP (NNS antibiotics)))))
        (, ,)
        (VP (VBN disaggregated))
        (CC and)
        (VP (VBN placed)
          (PP (IN into)
            (NP (NN MWRIα) (NN medium)))
          (S
            (VP (VBG -LSB-)
              (NP (CD 7) (NNS -RSB-))
              (PP (IN on)
                (NP
                  (NP (DT a) (JJ thin) (NN coat))
                  (PP (IN of)
                    (NP (NN matrigel))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Peripheral) (NN blood) (NNS lymphocytes))
      (PRN (-LRB- -LRB-)
        (NP (NNP PBLs))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN obtained)
        (PP (IN with)
          (NP
            (NP (NN consent))
            (PP (IN from)
              (NP (JJ normal) (JJ healthy) (NN control) (NNS subjects) (NNS ages)))))
        (NP
          (NP (CD 20) (: --) (CD 50))
          (VP (VBG working)
            (PP (IN at)
              (NP
                (NP (NNP Magee-Womens) (NNP Hospital))
                (CC or)
                (NP (NNS students))))
            (PP (IN at)
              (NP
                (NP (DT the) (NNP University))
                (PP (IN of)
                  (NP (NNP Pittsburgh)))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Foreskin) (JJ fibroblast) (-LRB- -LRB-) (NNP FF) (-RRB- -RRB-) (NN tissue))
    (VP (VBD was)
      (VP
        (VP (VBN obtained)
          (PP (IN as)
            (NP
              (NP (VBN discarded) (NN tissue))
              (PP (IN from)
                (NP
                  (NP (JJ newborn) (NNS infants))
                  (PP (IN after)
                    (NP (NN circumcision))))))))
        (CC and)
        (VP (VBN utilized)
          (PP (IN between)
            (NP (NNS passages) (CD 7)
              (CC and)
              (CD 10))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NN control) (NNS populations))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB previously))
          (VBN described)
          (PP (IN in)
            (NP
              (NP (JJR greater) (NN detail))
              (VP (VBG -LSB-)
                (NP (CD 30,46) (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Breast) (NN tissue) (NNS samples))
      (PP (IN from)
        (NP (DT the) (CD two) (JJ new) (NN control) (NNS patients))))
    (VP (VBD were)
      (VP (VBN processed)
        (PP (IN in)
          (NP (DT the) (JJ same) (NN manner)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Primary) (NNS cultures))
      (PP (IN of)
        (NP (JJ mammary) (NN tissue)))
      (, ,)
      (VP (VBN established)
        (NP
          (NP (CD 10))
          (: --)
          (NP (CD 14) (NNS days))))
      (, ,))
    (VP (VBD were)
      (VP (VBN labeled)
        (PP (IN with)
          (ADJP (JJ 3H-thymidine)))
        (PP (IN for)
          (NP
            (NP (DT a) (NN period))
            (PP (IN of)
              (NP
                (NP (CD 2) (NNS hours))
                (VP
                  (VP (VBN followed)
                    (PP (IN by)
                      (NP
                        (NP (DT a) (NN chase))
                        (PP (IN with)
                          (NP
                            (NP (JJ cold) (NN thymidine))
                            (PP (IN for)
                              (NP (CD 2) (NNS hours))))))))
                  (CC and)
                  (VP
                    (ADVP (RB then))
                    (VBN processed)
                    (PP (IN for)
                      (NP (NN autoradiography)))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP (DT a)
        (NP (CD 10) (: --) (CD 12))
        (NN day) (NN exposure)))
    (, ,)
    (NP (NNP slides))
    (VP (VBD were)
      (VP (VBN processed)
        (CC and)
        (VBN analyzed)
        (PP (IN by)
          (NP
            (NP (CD two) (JJ independent) (, ,) (JJ blinded) (NNS scorers))
            (SBAR
              (WHNP (WP who))
              (S
                (VP (VBN evaluated)
                  (NP (DT the) (NN tissue) (NNS samples))
                  (PP (IN for)
                    (NP
                      (NP (DT the) (NN percentage))
                      (PP (IN of)
                        (NP
                          (NP (NNS cells))
                          (PP (IN in)
                            (NP (NNP S) (NN phase)))
                          (PRN (-LRB- -LRB-)
                            (VP (VBN characterized)
                              (PP (IN by)
                                (NP
                                  (NP (JJ complete) (NN coverage))
                                  (PP (IN of)
                                    (NP
                                      (NP (DT the) (NN nucleus))
                                      (PP (IN with)
                                        (NP (JJ silver) (NNS grains))))))))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP NER))
    (VP (VBD was)
      (VP (VBN measured)
        (PP (IN by)
          (NP
            (NP (NN autoradiography))
            (PP (IN of)
              (NP (JJ unscheduled) (NN DNA) (NN synthesis)))))
        (SBAR (IN after)
          (S
            (NP
              (NP (NNP UV) (NN damage))
              (PRN (-LRB- -LRB-)
                (NP (NNP UDS))
                (-RRB- -RRB-)))
            (VP (VBZ -LSB-)
              (NP (CD 47,48) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP
          (NP (DT a) (NN total))
          (PP (IN of)
            (NP (CD 10))))
        (: --)
        (NP
          (NP (CD 14) (NNS days))
          (PP (IN in)
            (NP (NN culture))))))
    (, ,)
    (PP (IN without)
      (NP (NN passaging)))
    (, ,)
    (NP (NNS cultures))
    (VP (VBD were)
      (VP (VBN irradiated)
        (PP (IN with)
          (NP (NNP UV) (NN light)))
        (PP (IN at)
          (NP
            (NP (CD 254) (NN nm))
            (PP (IN at)
              (NP
                (NP (DT a) (JJ mean) (NN fluence))
                (PP (IN of)
                  (NP
                    (NP (CD 1.2) (NNS Joules/m2))
                    (PP (IN for)
                      (NP
                        (NP (CD 12) (NNS seconds))
                        (PP (IN in)
                          (NP
                            (NP (DT the) (NN absence))
                            (PP (IN of)
                              (NP (NN culture) (NN medium)))))))))))))
        (, ,)
        (PP (IN for)
          (NP
            (NP (DT a) (JJ total) (NN dose))
            (PP (IN of)
              (NP (CD 14) (NNS J/m2)))))))
    (. .)))

(ROOT
  (S
    (NP (DT Each) (NN sample))
    (VP (VBD was)
      (VP (VBN represented)
        (PP (IN by)
          (NP
            (QP (IN at) (JJS least) (CD two))
            (NN chamber) (NNS slides)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (CD One) (NN chamber))
      (PP (IN of)
        (NP (DT each) (JJ 2-chamber) (NN slide))))
    (VP (VBD was)
      (VP (VBN shielded)
        (PP (IN from)
          (NP (DT the) (NNP UV) (NN dose)))
        (S
          (VP (TO to)
            (VP (VB be)
              (VP (VBN used)
                (PP (IN as)
                  (NP (DT an) (JJ unirradiated) (NN control) (NN sample)))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (JJ Primary) (NNS cultures))
      (VP
        (VP (VBD had) (RB not)
          (VP (VBN reached)
            (NP (NN confluence))))
        (CC and)
        (VP (VBD were)
          (ADVP (RB still))
          (ADJP (RB actively) (JJ growing)
            (PP (IN at)
              (NP (DT the) (NN time)))))))
    (NP (DT the) (NNP UDS) (NN assay))
    (VP (VBD was)
      (VP (VBN performed)))
    (. .)))

(ROOT
  (S
    (NP (NNP Control) (NNP FF))
    (VP (VBD were)
      (VP (VBN plated)
        (ADVP (RB subconfluently))
        (PP
          (NP (CD 2) (NNS days))
          (IN before)
          (NP (DT the) (NNP UDS) (NN assay)))
        (S
          (VP (TO to)
            (VP (VB insure)
              (SBAR (IN that)
                (S
                  (NP (PRP they))
                  (ADVP (RB also))
                  (VP (VBD were) (RB not)
                    (PP (IN in)
                      (NP
                        (NP (DT a) (JJ quiescent) (NN state))
                        (VP (VBN brought)
                          (PRT (RP on))
                          (PP (IN by)
                            (NP (NN confluence))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP (NNP UV) (NN exposure)))
    (, ,)
    (NP (DT all) (NNS cultures))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN in)
          (NP
            (NP (NN medium))
            (VP (VBN supplemented)
              (PP (IN with)
                (NP
                  (NP
                    (NP (CD 10) (NN μCi) (NN ml) (NNS -LSB-))
                    (ADJP
                      (ADJP
                        (NP (CD 3H) (NNS -RSB-))
                        (JJ methyl-thymidine))
                      (PRN (-LRB- -LRB-)
                        (ADVP (RB ~))
                        (ADJP
                          (NP (CD 80) (NNS Ci))
                          (JJ mmol-1))
                        (-RRB- -RRB-))))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP PerkinElmer) (NNP Life) (NNP Sciences))
                    (, ,)
                    (NP (NNP Boston))
                    (, ,)
                    (NP (NNP MA))
                    (-RRB- -RRB-))))
              (SBAR (IN for)
                (S
                  (NP
                    (NP (CD 2) (NNS hours))
                    (PP (IN at)
                      (NP (CD 37) (JJ °) (NNP C.) (NNP Labeling) (NN medium))))
                  (VP (VBD was)
                    (VP
                      (VP
                        (ADVP (RB then))
                        (VBN replaced)
                        (PP (IN with)
                          (ADJP (JJ unlabeled)))
                        (S
                          (VP (VBG chasing)
                            (NP (NN medium))
                            (S
                              (VP (VBG containing)
                                (NP
                                  (NP (CD 10-3) (NNP M) (NN non-radioactive) (NN thymidine))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NNP Sigma))
                                    (-RRB- -RRB-))))))))
                      (CC and)
                      (VP (VBN incubated)
                        (PP (IN for)
                          (NP (DT a) (JJ further) (CD 2) (NNS hours)))
                        (S
                          (VP (TO to)
                            (VP (VB clear)
                              (NP (JJ radioactive) (NN label))
                              (PP (IN from)
                                (NP (DT the) (JJ intracellular) (JJ nucleotide) (NNS pools))))))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NN incubation))
        (PP (IN in)
          (NP (DT the) (JJ post-labeling) (NN medium)))))
    (, ,)
    (NP (NNS cells))
    (VP (VBD were)
      (VP
        (VP (VBN fixed)
          (PP (IN in)
            (NP
              (NP (CD 1X) (NN SSC))
              (, ,)
              (NP
                (NP
                  (ADJP (CD 33) (NN %))
                  (JJ acetic) (NN acid))
                (PP (IN in)
                  (NP (NN ethanol)))))))
        (, ,)
        (VP (VBN followed)
          (PP (IN by)
            (NP
              (ADJP (CD 70) (NN %))
              (NN ethanol))))
        (CC and)
        (VP
          (ADVP (RB finally))
          (VBN rinsed)
          (PP (IN in)
            (NP
              (NP
                (ADJP (CD 4) (NN %))
                (JJ perchloric) (NN acid))
              (PP (IN over)
                (NP (NN night)))))
          (PP (IN at)
            (NP
              (NP (CD 4) (NNP °) (NNP C.))
              (SBAR
                (S
                  (NP (DT All) (NN slides))
                  (VP (VBD were)
                    (ADJP (JJ dried))))))))
        (CC and)
        (VP
          (ADVP (RB subsequently))
          (VBN dipped)
          (PP (IN in)
            (NP
              (NP (JJ photographic) (NN emulsion))
              (PRN (-LRB- -LRB-)
                (NP (NNP Kodak) (NNP type) (NNP NTB2))
                (-RRB- -RRB-)))))
        (CC and)
        (VP (VBN exposed)
          (PP (IN for)
            (NP
              (NP
                (QP (CD 10) (TO to) (CD 14))
                (NNS days))
              (PP (IN in)
                (NP (JJ complete) (NNS darkness)))))
          (PP (IN at)
            (NP (CD 4) (NN °) (NNP C))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN length))
      (PP (IN of)
        (NP
          (NP (NN exposure))
          (PP (IN of)
            (NP (NN emulsion))))))
    (VP (VBD was)
      (VP (VBN determined)
        (PP (IN in)
          (NP (DT each) (NN experiment)))
        (PP (IN by)
          (S
            (VP (VBG preparing)
              (NP
                (NP (NNP FF) (`` ``) (NN tester) ('' ''))
                (SBAR
                  (S
                    (VP (VBZ slides))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP (CD 10)))
    (: --)
    (NP
      (NP
        (NP (CD 12) (NNS days))
        (SBAR
          (S
            (NP (DT these) (NN tester) (NN slides))
            (VP (VBD were)
              (VP (VBN developed))))))
      (CC and)
      (NP (NN grain) (VBG counting)))
    (VP (VBD was)
      (VP (VBN performed)))
    (. .)))

(ROOT
  (S
    (SBAR (IN If)
      (S
        (NP
          (NP (DT the) (NN nuclei))
          (PP (IN over)
            (NP (DT the) (NN foreskin) (NNS fibroblasts))))
        (VP (VBD averaged)
          (NP
            (NP
              (QP (CD 50)
                (CC or)
                (JJR more))
              (NNS grains))
            (PP (IN per)
              (NP (NN nucleus)))))))
    (, ,)
    (NP
      (NP (RB then) (DT the) (NN rest))
      (PP (IN of)
        (NP (DT the) (JJ experimental) (NN slides))))
    (VP (VBD were)
      (VP (VBN developed)))
    (. .)))

(ROOT
  (S
    (SBAR (IN If)
      (S
        (NP (DT the) (NN grain) (NN count))
        (VP (VBD was)
          (PP (IN below)
            (NP (DT this) (NN level))))))
    (, ,)
    (NP (DT the) (VBG remaining) (NN slides))
    (VP (VBD were)
      (VP (VBN left)
        (S
          (VP (TO to)
            (VP (VB expose)
              (NP (CD 1))
              (: --)
              (PP
                (ADVP
                  (NP (CD 3) (NNS days))
                  (RBR longer))
                (IN before)
                (S
                  (VP (VBG being)
                    (VP (VBN developed))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (JJ photographic) (NN development))
        (PP (IN of)
          (NP (NN emulsion)))))
    (, ,)
    (NP (DT all))
    (VP (VBZ slides)
      (S
        (S
          (VP (VBD were)
            (VP (VBN stained)
              (PP (IN with)
                (NP (NNP Giemsa))))))
        (, ,) (RB then)
        (S
          (VP (VBN examined)
            (PP (IN at)
              (NP
                (NP (DT a) (JJ total) (NN magnification))
                (PP (IN of)
                  (NP
                    (NP (CD 1000X))
                    (PP (IN on)
                      (NP (DT a) (NNP Zeiss) (NNP Axioskop)))))))
            (PP (IN under)
              (NP
                (NP (NN oil) (NN emersion))
                (PP (IN for)
                  (NP
                    (NP (NNS grains))
                    (VP (VBN located)
                      (ADVP (RB immediately))
                      (PP (IN over)
                        (NP
                          (NP (DT the) (NN nuclei))
                          (PP (IN of)
                            (NP (JJ non-S) (NN phase) (NNS cells)))))
                      (S
                        (VP (VBG -LSB-)
                          (NP (CD 48) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (JJ Local) (NN background) (NN grain) (NNS counts))
      (VP (VBD were)
        (VP (VBN evaluated)
          (PP (IN in)
            (NP
              (NP (DT each) (JJ microscopic) (NN field))
              (PP (IN over)
                (NP (DT an) (NN area)))))
          (NP
            (NP (DT the) (JJ same) (NN size))
            (PP (IN as)
              (NP (DT a) (JJ representative) (NN nucleus)))))))
    (, ,)
    (CC and)
    (S
      (NP (DT this) (NN total))
      (VP (VBD was)
        (VP (VBN subtracted)
          (PP (IN from)
            (NP
              (NP (DT the) (NN grain) (NN count))
              (PP (IN of)
                (NP
                  (NP (DT each) (NN nucleus))
                  (PP (IN in)
                    (NP (DT that) (NN field))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ average) (NN number))
      (PP (IN of)
        (NP
          (NP (NNS grains))
          (PP (IN per)
            (NP (NN nucleus))))))
    (VP (VBD was)
      (VP (VBN quantified)
        (PP (IN for)
          (NP
            (NP (DT each) (NN side))
            (PP (IN of)
              (NP (DT the) (NN chamber) (NN slide)))
            (, ,)
            (ADJP (DT both) (JJ unirradiated)
              (CC and)
              (JJ irradiated))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ final) (NNP NER) (NN value))
      (PP (IN for)
        (NP (DT each) (NN slide))))
    (VP (VBD was)
      (VP (VBN calculated)
        (PP (IN by)
          (S
            (VP (VBG subtracting)
              (NP
                (NP (DT the) (JJ unirradiated) (NN mean))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNS grains))
                    (PP (IN per)
                      (NP (NN nucleus))))
                  (-RRB- -RRB-)))
              (PP (IN from)
                (NP
                  (NP (DT the) (JJ irradiated) (NN mean))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNS grains))
                      (PP (IN per)
                        (NP (NN nucleus))))
                    (-RRB- -RRB-))))
              (, ,)
              (PP (IN after)
                (NP
                  (NP (DT the) (JJ initial) (NN subtraction))
                  (PP (IN of)
                    (NP
                      (NP (JJ local) (NN background))
                      (PP (IN in)
                        (NP (DT each) (NN field))))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP NER))
    (VP (VBD was)
      (ADVP (RB initially))
      (VP (VBN expressed)
        (PP (IN as)
          (NP
            (NP (DT a) (NN percentage))
            (PP (IN of)
              (NP
                (NP (DT the) (NN activity))
                (PP (IN of)
                  (NP (JJ concurrently) (NNP analyzed) (NNP FF)))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Four) (NNP FF) (NNP slides))
    (VP (VBD were)
      (VP (VBN scored)
        (PP (IN per)
          (NP (NN experiment)))
        (, ,)
        (PP (IN by)
          (NP
            (NP (DT an) (NN average))
            (PP (IN of)
              (NP (CD three) (NNS counters)))))))
    (. .)))

(ROOT
  (S
    (NP (CD 200) (NNS nuclei))
    (VP (VBD were)
      (VP (VBN counted)
        (PP (IN per)
          (NP (NN slide)))
        (, ,)
        (PP (IN for)
          (NP
            (NP (DT a) (NN total))
            (PP (IN of)
              (NP (CD 800)))))
        (, ,)
        (PP (IN with)
          (NP
            (NP (DT an) (NN average))
            (PP (IN of)
              (NP (CD 61.6) (NNS grains/nucleus)))))))
    (. .)))

(ROOT
  (S
    (NP (CD Six) (NNS slides))
    (VP (VBD were)
      (VP (VBN evaluated)
        (PP (IN for)
          (NP
            (NP
              (NP (DT the) (NN patient) (POS 's))
              (NNP PBL) (NN sample))
            (, ,)
            (NP (CD two))))
        (PP (IN by)
          (NP
            (NP (DT each))
            (PP (IN of)
              (NP (CD three) (NNS counters)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT An) (NN average))
      (PP (IN of)
        (NP (CD 195) (NNS nuclei))))
    (VP (VBD were)
      (VP (VBN scored)
        (PP (IN per)
          (NP
            (NP (NN slide))
            (PRN (-LRB- -LRB-)
              (PP (IN for)
                (NP
                  (NP (DT a) (NN total))
                  (PP (IN of)
                    (NP
                      (QP (RB almost) (CD 1200))))))
              (-RRB- -RRB-))))
        (, ,)
        (PP (IN with)
          (NP
            (NP (DT an) (NN average))
            (PP (IN of)
              (NP (CD 7.5) (NNS grains/nucleus)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Four) (NNP slides))
    (VP (VBD were)
      (VP (VBN counted)
        (PP (IN for)
          (NP
            (NP (DT the) (JJ contemporaneous) (NN breast) (NN reduction) (NN control))
            (, ,)
            (NP
              (NP (CD two))
              (NP (DT each)))))
        (PP (IN by)
          (NP (CD two) (NNS counters)))))
    (. .)))

(ROOT
  (S
    (NP (EX There))
    (VP (VBD were)
      (NP
        (NP (DT an) (NN average))
        (PP (IN of)
          (NP
            (NP (CD 200) (NNS nuclei))
            (PP (IN per)
              (NP
                (NP (NN slide))
                (CC and)
                (NP (CD 14.1) (NNS grains/nucleus))))))))
    (. .)))

(ROOT
  (S
    (NP (CD Six) (NNS slides))
    (VP (VBD were)
      (VP (VBN scored)
        (PP (IN from)
          (NP
            (NP
              (NP (DT the) (NN patient) (POS 's))
              (JJ ipsilateral) (NN breast) (NN tissue) (NN sample))
            (, ,)
            (SBAR
              (WHNP
                (WHNP (CD two))
                (PP (IN by)
                  (NP
                    (NP
                      (NP (DT each))
                      (PP (IN of)
                        (NP (CD three) (JJ independent) (NNS counters))))
                    (, ,)
                    (CC and)
                    (NP
                      (QP (CD five) (CD slides))))))
              (S
                (VP (VBD were)
                  (VP (VBN counted)
                    (PP (IN from)
                      (NP (DT the) (JJ contralateral) (NN sample)))
                    (, ,)
                    (ADVP (RB again)
                      (PP (IN by)
                        (NP (CD three) (JJ independent) (NNS counters))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT An) (NN average))
      (PP (IN of)
        (NP
          (QP (RB just) (IN over) (CD 100))
          (NNS nuclei))))
    (VP (VBD were)
      (VP (VBN evaluated)
        (PP
          (PP (IN per)
            (NP
              (NP (NN slide))
              (PP (IN for)
                (NP (DT each) (NN sample)))))
          (, ,)
          (PP (IN for)
            (NP
              (NP (DT a) (NN total))
              (PP (IN of)
                (NP
                  (NP
                    (QP (RB almost) (CD 600))
                    (NNS nuclei))
                  (PP (IN for)
                    (NP (DT the) (JJ ipsilateral) (NN sample)))))))
          (CC and)
          (PP (IN over)
            (NP (CD 500))))
        (PP (IN for)
          (NP (DT the) (JJ contralateral) (NN sample)))))
    (. .)))

(ROOT
  (S
    (SBAR (IN As)
      (S
        (NP (DT the) (NNP NER) (NNS capacities))
        (VP (VBP indicate))))
    (, ,)
    (NP (DT these) (NNS samples))
    (VP (VBD had)
      (NP
        (NP
          (NP
            (ADJP (RB very) (JJ similar))
            (NNS counts))
          (: ;)
          (NP
            (NP
              (QP (RB about) (CD 35))
              (NNS grains/nucleus))
            (PP (IN for)
              (NP (DT the) (JJ ipsilateral) (NN sample)))))
        (CC and)
        (NP
          (NP (CD 28) (NNS grains/nucleus))
          (PP (IN for)
            (NP (DT the) (JJ contralateral) (NN sample))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Finally))
    (, ,)
    (NP (CD four) (NNS slides))
    (VP (VBD were)
      (VP (VBN counted)
        (PP (IN from)
          (NP
            (NP (DT the) (JJ contralateral) (NN sample))
            (PP (IN of)
              (NP (DT a) (JJ sporadic) (NN breast) (NN cancer) (NN patient)))))
        (, ,)
        (PP (IN by)
          (NP (CD three) (NNS counters)))))
    (. .)))

(ROOT
  (S
    (NP (EX There))
    (VP (VBD were)
      (NP
        (NP (DT an) (NN average))
        (PP (IN of)
          (NP
            (NP
              (NP (CD 200) (NNS nuclei))
              (PP (IN per)
                (NP (NN slide))))
            (CC and)
            (NP
              (NP (CD 29.4) (NNS grains))
              (PP (IN per)
                (NP (NN nucleus))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB ensure)
          (NP (NN accuracy)
            (CC and)
            (NN guard))
          (PP (IN against)
            (NP (NN transcription) (NNS errors))))))
    (PRN (, ,)
      (S
        (S
          (NP
            (NP (JJ raw) (NN grain) (NNS counts))
            (PP (IN from)
              (NP (DT the) (NNP UDS) (NN assay))))
          (VP (VBD were)
            (VP (VBN processed)
              (ADVP (RB independently))
              (PP (IN in)
                (NP (NNP duplicate))))))
        (, ,)
        (ADVP (RB once))
        (S
          (VP (VBG using)
            (NP
              (NP (NNP StatView))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN version) (CD 5.0.1))
                  (, ,)
                  (NP (NNP SAS) (NNP Institute) (, ,) (NNP Inc.) (, ,) (NNP Cary) (, ,) (NNP NC)))
                (-RRB- -RRB-))))))
      (, ,))
    (CC and)
    (ADVP (RB once))
    (S
      (VP (VBG using)
        (NP
          (NP (DT the) (NNP Data) (NNP Analysis) (NNP Toolpack))
          (PP (IN of)
            (NP
              (NP (DT the) (NNP Excel) (CD 2001) (NN spreadsheet) (NN program))
              (PRN (-LRB- -LRB-)
                (NP (NNP Microsoft) (NNP Corp.))
                (, ,)
                (NP (NNP Redmond))
                (, ,)
                (NP (NNP WA))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ final) (NN count))
      (PP (IN from)))
    (VP
      (VP (VBZ slides)
        (PP (IN of)
          (NP
            (NP (DT the) (JJ same) (NN cell) (NN type))
            (PP (IN within)
              (NP (DT the) (JJ same) (NN experiment))))))
      (CC and)
      (VP (VBD developed)
        (SBAR
          (S
            (NP (DT the) (JJ same) (NN day))
            (VP (VBD were)
              (VP
                (VP (VBN averaged)
                  (ADVP (RB together)))
                (CC and)
                (VP (VBN expressed)
                  (PP (IN as)
                    (NP
                      (NP (DT a) (NN percentage))
                      (PP (IN of)
                        (NP (JJ concurrently) (NNP analyzed) (NNP FF))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS results))
    (VP (VBD were)
      (VP
        (ADVP (RB then))
        (VBN normalized)
        (PP (IN by)
          (NP (NN comparison)))
        (PP (TO to)
          (NP
            (NP (DT the) (NN average))
            (PP (IN for)
              (NP (DT the) (NN tissue) (NN type) (NN control) (NN population)))))
        (S
          (VP (VBG -LSB-)
            (NP (CD 48) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (VBG Competing) (NNS interests)))
    (NP (DT The) (NNS authors))
    (VP (VBP declare)
      (SBAR (IN that)
        (S
          (NP (PRP they))
          (VP (VBP have)
            (NP (DT no) (VBG competing) (NNS interests))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Authors) (POS '))
      (NNS contributions))
    (VP
      (VP
        (ADVP (RB JJL))
        (VBD conceived)
        (PP (IN of)
          (NP (DT the) (NN study))))
      (, ,)
      (VP (VBD executed)
        (NP (PRP it)))
      (, ,)
      (CC and)
      (VP (VBD drafted)
        (NP (DT the) (NN manuscript))))
    (. .)))

(ROOT
  (S
    (NP (NNP WSR))
    (VP (VBD recruited)
      (CC and)
      (VBD consented)
      (NP
        (NP (DT the) (NN patient))
        (, ,)
        (VP (VBN provided)
          (NP
            (NP (JJ clinical) (NNS samples))
            (CC and)
            (NP (NN information))))))
    (. .)))

(ROOT
  (S
    (NP (NNP JMJ))
    (VP
      (VP (VBZ evaluated)
        (NP (DT the) (NNP UDS) (NN assay)))
      (CC and)
      (VP (VBD analyzed)
        (NP (DT the) (NNS data))))
    (. .)))

(ROOT
  (S
    (NP (NNP AKS))
    (VP (VBD performed)
      (NP
        (NP (DT the) (JJ histopathological) (NN analysis))
        (PP (IN of)
          (NP (DT the) (NN tissue)))))
    (. .)))

(ROOT
  (S
    (NP (NNP VGV))
    (VP (VBD participated)
      (PP (IN in)
        (NP (DT the) (NN study) (NN design)
          (CC and)
          (NNS data) (NN interpretation))))
    (. .)))

(ROOT
  (S
    (NP (NNP SGG))
    (VP
      (VP (VBD participated)
        (PP (IN in)
          (NP
            (NP (DT the) (NN design)
              (CC and)
              (NN coordination))
            (PP (IN of)
              (NP (DT the) (NN study))))))
      (CC and)
      (VP (VBD helped)
        (S
          (VP (TO to)
            (VP (VB draft)
              (NP (DT the) (NN manuscript)))))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (JJ Pre-publication) (NN history))
      (SBAR
        (S
          (NP
            (NP (DT The) (JJ pre-publication) (NN history))
            (PP (IN for)
              (NP (DT this) (NN paper))))
          (VP (MD can)
            (VP (VB be)
              (VP (VBN accessed)
                (ADVP (RB here))))))))
    (: :)
    (NP
      (NP (NNP Figure)
        (CC and)
        (NNP Table) (NNS captions))
      (NP (NNP Figure) (CD 1)))
    (: :)
    (NP
      (NP (NNP Pedigree))
      (PP (IN of)
        (NP
          (NP (DT the) (NN patient))
          (PRN (-LRB- -LRB-)
            (VP (VBN indicated)
              (PP (IN by)
                (NP (NN arrow))))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (PRP She))
        (, ,)
        (NP (CD one) (JJ maternal) (NN aunt))
        (CC and)
        (NP (CD one) (JJ maternal) (NN cousin)))
      (VP (VBD had)
        (NP
          (NP (NN breast) (NN cancer))
          (SBAR
            (S
              (VP (VBD diagnosed)
                (PP (IN at)
                  (UCP
                    (NP (CD 36))
                    (, ,)
                    (NP (CD 44))
                    (CC and)
                    (ADJP
                      (NP (CD 41) (NNS years))
                      (JJ old))))
                (, ,)
                (ADVP (RB respectively))
                (, ,)
                (SBAR (IN as)
                  (S
                    (VP (VBD indicated)
                      (PP (IN by)
                        (NP (DT the) (JJ half-filled) (NNS symbols))))))))))))
    (, ,)
    (CC and)
    (S
      (NP (PRP$ her) (NN aunt))
      (VP (VBD died)
        (PP (IN of)
          (NP (DT the) (NN disease)))))
    (. .)))

(ROOT
  (S
    (NP (PRP$ Her) (NN cousin))
    (VP
      (VP (VBD underwent)
        (SBAR
          (S
            (NP (NN lumpectomy))
            (VP (VBD followed)
              (PP (IN by)
                (NP (NN chemotherapy)))
              (, ,)
              (ADVP (RB radiotherapy))))))
      (CC and)
      (VP (VBZ is)
        (ADVP (RB presently))
        (PP (IN on)
          (NP (NN tamoxifen)))))
    (. .)))

(ROOT
  (S
    (NP (PRP$ Her) (NN mother))
    (VP
      (VP (VBD had)
        (NP
          (NP (NN breast) (NN cancer))
          (PP (IN in)
            (NP (DT both) (NNS breasts)))))
      (, ,)
      (VP (VBD diagnosed)
        (PP (IN at)
          (NP (NNS ages) (CD 41)
            (CC and)
            (CD 42))))
      (, ,)
      (SBAR (IN as)
        (S
          (VP (VBD indicated)
            (PP (IN by)
              (NP (DT the)
                (ADJP (RB completely) (JJ filled))
                (NN symbol)))))))
    (. .)))

(ROOT
  (S
    (NP (PRP She))
    (VP
      (VP (VBD underwent)
        (NP (JJ bilateral) (NN mastectomy)
          (CC and)
          (NN hysterectomy))
        (PP (VBN followed)
          (PP (IN by)
            (NP (NN chemotherapy)
              (CC and)
              (NN radiotherapy)))))
      (CC and)
      (VP (VBD died)
        (PP (IN of)
          (NP (DT the) (NN disease)))
        (PP (IN at)
          (NP (NN age) (CD 44)))))
    (. .)))

(ROOT
  (S
    (NP (DT A) (JJ second) (JJ maternal) (NN aunt))
    (VP (VBD was)
      (VP (VBN diagnosed)
        (PP (IN with)
          (NP (NN colon) (NN cancer)))
        (PP (IN at)
          (NP
            (NP
              (NP (NN age) (CD 52))
              (PRN (-LRB- -LRB-)
                (NP (JJ light) (JJ half-filled) (NN symbol))
                (-RRB- -RRB-)))
            (CC and)
            (NP
              (NP (NN breast) (NN cancer))
              (PP (IN at)
                (NP
                  (NP (NN age) (CD 55))
                  (PRN (-LRB- -LRB-)
                    (NP (JJ dark) (JJ half-filled) (NN symbol))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (PP (VBN Based)
      (PP (IN on)
        (NP
          (NP (DT this) (NN pattern))
          (PP (IN of)
            (NP (JJ familial) (NN cancer))))))
    (NP (DT the) (NN patient))
    (VP
      (VP (VBD was)
        (VP (VBN considered)
          (S
            (VP (TO to)
              (VP (VB be)
                (PP (IN at)
                  (NP
                    (NP (JJ high) (NN risk))
                    (PP (IN of)
                      (NP (VBG developing) (NN breast) (NN cancer))))))))))
      (CC and)
      (VP (VBD was)
        (VP (VBN entered)
          (PP (IN into)
            (NP (DT the) (JJ low) (NN power) (NN MRI) (NN screening) (NN validation)
              (CC and)
              (NN feasibility) (NN study))))))
    (. .)))

(ROOT
  (S
    (PP (VBG Following)
      (NP (PRP$ her) (NN diagnosis)))
    (, ,)
    (NP (PRP she))
    (VP (VBD was)
      (VP (VBN confirmed)
        (PP (IN as)
          (S
            (VP (VBG carrying)
              (NP (DT a) (JJ Q1200X) (NN mutation))
              (PP (IN in)
                (NP (DT the) (NNP BRCA1) (NN gene))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 2))
    (: :)
    (NP
      (NP (NNP Ultrasound))
      (PP (IN of)
        (NP (DT the) (JJ MRI-detected) (NN lesion))))
    (. .)))

(ROOT
  (S
    (PP (VBG Following)
      (NP (NNP MRI)))
    (, ,)
    (NP (DT the) (NN patient))
    (VP (VBD was)
      (VP (VBN scheduled)
        (PP (IN for)
          (NP (NN ultrasound)))
        (S
          (VP (TO to)
            (VP (VB identify)
              (NP
                (NP (DT the) (JJ questionable) (NNS lesions))
                (VP (VBN seen)
                  (PP (IN on)
                    (NP
                      (NP (NNP MRI))
                      (PP (IN for)
                        (NP (JJ possible) (NN core) (NN biopsy))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN Under)
      (NP (NN ultrasound)))
    (NP
      (NP (DT the) (NN lesion))
      (PP (IN of)
        (NP (NN concern))))
    (VP (VBD was)
      (VP (VBN identified)
        (CC and)
        (VBN biopsied)
        (PP (IN at)
          (NP
            (NP (DT the) (CD 1:00) (NN location))
            (PP (IN in)
              (NP (DT the) (JJ left) (NN breast)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Additionally))
    (, ,)
    (NP
      (NP (CD one) (NN lesion))
      (VP (VBN seen)
        (PP (IN by)
          (NP (NNP MRI)))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ right) (NN breast))
            (PP (IN at)
              (NP (DT the) (CD 4:00) (NN location)))))))
    (VP (VBD was)
      (VP (VBN identified)
        (CC and)
        (VBN biopsied)))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 3))
    (: :)
    (NP
      (NP (NNP Micrographs))
      (PP (IN of)
        (NP
          (NP
            (NP (DT the) (JJ non-diseased) (JJ primary) (JJ human) (JJ mammary) (JJ epithelial) (NNS cultures))
            (PRN (-LRB- -LRB-)
              (NP (NNP HMEC))
              (-RRB- -RRB-)))
          (PP (IN from)
            (NP (DT the) (NNP BRCA1) (NN mutation) (NN carrier))))))
    (. .)))

(ROOT
  (S
    (PP
      (NP (DT A) (-RRB- -RRB-) (NNP Contralateral))
      (IN breast))
    (: --)
    (NP
      (NP (DT A) (NN cluster))
      (PP (IN of)
        (NP (JJ epithelial) (NNS cells))))
    (VP (VBD called)
      (SBAR
        (S
          (NP (DT a) (NN mammosphere))
          (VP (VBZ is)
            (VP (VBN shown)
              (PP (IN on)
                (NP
                  (NP (DT the) (JJ left) (NN center))
                  (PP (IN of)
                    (NP
                      (NP (DT the) (NN image))
                      (VP (VBG sitting)
                        (PP (IN on)
                          (NP
                            (NP (DT a) (NN field))
                            (PP (IN of)
                              (NP (NNS fibroblasts)))))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP
        (VP (VB B) (-RRB- -RRB-)
          (NP (NNP Ipsilateral))
          (ADVP (RB breast)))
        (: --)
        (NP
          (NP (DT The) (JJ original) (JJ fresh) (NN tissue) (NN block))
          (SBAR
            (WHPP (IN from)
              (WHNP (WDT which)))
            (S
              (NP (DT this) (NN culture))
              (VP (VBD was)
                (VP (VBN derived))))))))
    (VP (VBD was)
      (VP (VBN located)
        (NP
          (NP (CD 4) (NN cm))
          (PP (IN from)
            (NP (DT the) (JJ infiltrating) (JJ ductal) (NN carcinoma))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN structure))
      (VP (VBN shown)))
    (VP (VBZ is)
      (NP
        (NP (DT a) (NN cluster))
        (PP (IN of)
          (NP
            (NP
              (ADJP (JJ rounded) (JJ epithelial))
              (NNS cells))
            (VP (VBG manifesting)
              (NP
                (NP (DT a) (NN column) (NN configuration))
                (VP (VBN called)
                  (NP (`` ``) (JJ pre-ductal) (NN linearization) ('' '')))))))))
    (. .)))

(ROOT
  (S
    (NP (DT Both) (NNS images))
    (VP (VBD were)
      (VP (VBN captured)
        (PP (IN under)
          (NP
            (NP (NNP Differential) (NNP Interference) (NNP Contrast)
              (PRN (-LRB- -LRB-)
                (NP (NNP DIC))
                (-RRB- -RRB-))
              (NNS optics))
            (PP (IN on)
              (NP
                (NP (DT a) (NNP Zeiss) (NN Axiovert) (CD 100) (NN microscope))
                (PP (IN at)
                  (NP
                    (NP (DT a) (NN total))
                    (PP (IN of)
                      (NP (JJ 140x) (NN magnification)))))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 4))
    (: :)
    (NP
      (NP (NNP Comparison))
      (PP (IN of)
        (NP
          (NP (DT the) (NNP NER) (NN capacity))
          (PP (IN of)
            (NP
              (NP (DT a) (NNP PBL) (NN sample))
              (PP (IN from)
                (NP
                  (NP (PRP$ our) (JJ BRCA1) (NN mutation) (NN carrier) (NN patient))
                  (PP (IN with)
                    (NP
                      (NP (DT those))
                      (PP (IN of)
                        (NP
                          (NP (DT a) (NN population))
                          (PP (IN of)
                            (NP (JJ disease-free) (NNS controls))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ dark) (JJ horizontal) (NN line))
    (VP (VBZ indicates)
      (NP
        (NP (DT the) (NN average))
        (PP (IN for)
          (NP (DT the) (JJ normal) (NN population))))
      (, ,)
      (SBAR (IN while)
        (S
          (NP (DT the) (JJ dotted) (NNS lines))
          (VP (VBP indicate)
            (NP
              (NP (JJ upper) (NNS limits))
              (PP (IN for)
                (NP (JJ residual) (NNP NER) (NN activity))))
            (PP (IN in)
              (NP
                (NP
                  (NP (NNS patients))
                  (PP (IN with)
                    (NP
                      (NP (DT the) (NNP hereditary) (NNP NER) (NN deficiency) (NN disease) (NN XP))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 0.50))
                        (-RRB- -RRB-)))))
                (CC and)
                (NP
                  (NP (DT the) (NN cut-off))
                  (VP (VBN established)
                    (PP (IN in)
                      (NP
                        (NP (PRP$ our) (NN breast) (NN tissue) (NN study))
                        (SBAR
                          (WHNP (WDT that))
                          (S
                            (VP (VBD identified)
                              (NP (NNS tumors))
                              (PP (IN with)
                                (NP (JJ high) (NN sensitivity)
                                  (CC and)
                                  (NN specificity))))))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 0.70))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 5))
    (: :)
    (NP
      (NP (NNP Comparison))
      (PP (IN of)
        (NP
          (NP (DT the) (NNP NER) (NNS capacities))
          (PP (IN of)
            (NP
              (NP (CD two) (NNS samples))
              (PP (IN of)
                (NP
                  (NP (JJ normal) (NN breast) (NN epithelium))
                  (PP (IN from)
                    (NP
                      (NP (PRP$ our) (JJ BRCA1) (NN mutation) (NN carrier) (NN patient))
                      (PP (IN with)
                        (NP
                          (NP (DT those))
                          (PP (IN of)
                            (NP
                              (NP (DT a) (NN population))
                              (PP (IN of)
                                (NP (JJ disease-free) (NNS controls)))))))))))))))
      (SBAR
        (WHNP (WP who))
        (S
          (VP (VBD underwent)
            (NP (NN breast) (NN reduction))
            (ADVP (RB mammoplasty))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ dark) (JJ horizontal) (NN line))
    (VP (VBZ indicates)
      (NP
        (NP (DT the) (NN average))
        (PP (IN for)
          (NP
            (NP (DT the) (JJ normal) (NN population))
            (PP (IN of)
              (NP
                (NP (NN breast) (NN reduction) (NN epithelium))
                (PRN (-LRB- -LRB-)
                  (NP (NNP BRE))
                  (-RRB- -RRB-)))))))
      (, ,)
      (SBAR (IN while)
        (S
          (NP (DT the) (JJ dotted) (NNS lines))
          (VP (VBP indicate)
            (NP
              (NP (JJ upper) (NNS limits))
              (PP (IN for)
                (NP (JJ residual) (NNP NER) (NN activity))))
            (PP (IN in)
              (NP
                (NP
                  (NP (NNS patients))
                  (PP (IN with)
                    (NP
                      (NP (DT the) (NNP hereditary) (NNP NER) (NN deficiency) (NN disease) (NN XP))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 0.50))
                        (-RRB- -RRB-)))))
                (CC and)
                (NP
                  (NP (DT the) (NN cut-off))
                  (VP (VBN established)
                    (PP (IN in)
                      (NP
                        (NP (PRP$ our) (NN breast) (NN tissue) (NN study))
                        (SBAR
                          (WHNP (WDT that))
                          (S
                            (VP (VBD identified)
                              (NP (NNS tumors))
                              (PP (IN with)
                                (NP (JJ high) (NN sensitivity)
                                  (CC and)
                                  (NN specificity))))))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 0.70))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ patient) (NN sample))
      (PP (IN on)
        (NP (DT the) (NN left))))
    (VP (VBD was)
      (VP (VBN derived)
        (PP (IN from)
          (NP
            (NP (DT the) (JJ ipsilateral)
              (PRN (-LRB- -LRB-)
                (VP (VBN left))
                (-RRB- -RRB-))
              (NN breast))
            (, ,)
            (SBAR (IN while)
              (S
                (NP
                  (NP (DT the) (NN sample))
                  (PP (IN on)
                    (NP (DT the) (NN right))))
                (VP (VBD was)
                  (PP (IN from)
                    (NP (DT the) (JJ contralateral)
                      (PRN (-LRB- -LRB-)
                        (NP (NN right))
                        (-RRB- -RRB-))
                      (NN breast))))))))))
    (. .)))

